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Individuals with Type 2 diabetes often do not adhere to their treatment regimens (e.g., 
exercise, diet, medication, glucose monitoring). Non-adherence results in poor metabolic 
control, further morbidity and mortality, and increased health care utilization and costs. 
One common thread among many health behavior theories attempting to explain non-
adherence behaviors is the importance of perceived control. This psychosocial variable 
has most often been conceptualized as ‘health locus of control,’ which refers to the belief 
that one has the ability to influence or change one’s health outcomes. Inconsistent 
findings have been reported regarding the relationship of health locus of control and 
medical regimen adherence in individuals with Type 2 diabetes. These inconsistencies 
may be related to a need for further research focused on the interaction of internal locus 
with other perceived control constructs (e.g., self efficacy and outcome expectancy) as 
well as other types of external loci of control. The present study examined the 
relationship between internal locus of control, self-efficacy, and outcome expectancy on 
medical regimen adherence behaviors in low-income adults with Type 2 diabetes. It also 
investigated the influence of four types of external loci of control, independent and when 
combined with internal locus of control, on medical regimen adherence in Type 2 
diabetic patients. A biological marker, HbA1c, which is considered the most reliable 
medical indicator for medical regimen adherence behaviors of diabetic patients, was used 
to measure medical regimen adherence. Multiple regression analyses demonstrate that 
though self efficacy, in its solidarity, was the best predictor of medical regimen 
adherence, as indicated by HbA1c levels, the interaction of high internal locus of control 
and high outcome expectancy was also meaningfully linked to medical regimen 
 xi 
adherence. Further, results suggest that high internal locus of control and low chance 
locus of control beliefs are significantly related to medical regimen adherence in this 





























                                                                                               
 1 
INTRODUCTION 
The number of cases of diabetes mellitus has increased consistently over the past decade 
(Centers for Disease Control [CDC], 1999).  The CDC recently approximated that 15.7 million 
persons (5.9% of the total population) in the United States have been diagnosed with diabetes 
(CDC, 1999). Of the patients diagnosed with diabetes, 90% to 95% have been diagnosed with 
non- insulin dependent diabetes mellitus, also referred to as Type 2 diabetes. In Type 2 diabetes 
endogenous insulin in individuals becomes metabolically inefficient because of insulin resistance 
in tissues (Porte & Sherwin, 1997). Type 2 diabetes is often highly correlated with obesity, and 
other risk factors, including age, gender, and race. The majority of people diagnosed with Type 2 
diabetes are overweight, sedentary, and do not adhere to a low-fat diet (ADA, 1998; Porte & 
Sherwin, 1997).  It is most often diagnosed in individuals over the age of 30 years and Type 2 
diabetes equally affects females (8.2%) and males (8.2%) in the United States (CDC, 1999). 
The prevalence of Type 2 diabetes is extremely high in Blacks when compared to other 
groups in the United States, particularly Whites (American Diabetes Association [ADA], 1994).  
Black females are principally at risk for developing diabetes. Prevalence reports conducted by 
the ADA suggest that Black women have the highest prevalence and mortality rates for Type 2 
diabetes in the United States and are the fastest growing group of Americans being diagnosed 
with the disease (CDC, 1999). The increased risk of Black females for developing Type 2 
diabetes is directly related to high rates of obesity, sedentary lifestyle, and high-fat dietary intake 
commonly found within this population (CDC, 1999).  
Health behavior change is the core of treatment for Type 2 diabetes because the risk 
factors associated with developing this disease are related to poor health behaviors. Patients are 
advised to follow a strict program of medication, diet, exercise, and blood glucose monitoring. 
This regimen must be followed on a daily basis for life (Cox & Gonder-Frederick, 1992). The 
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multifaceted nature of this treatment may contribute to poor adherence among individuals with 
Type 2 diabetes. If individuals do not adhere to these treatment recommendations, their diabetes 
is not controlled and the risk for developing future health problems increases. For example, 
diabetes remains one of the leading causes of death in the United States (CDC, 1999; 
Zimmerman, 1990) and is a risk factor for several other comorbid health conditions, including 
vascular and neuropathic conditions (Zimmerman, 1990).  Specifically, diabetic patients have 
macrovasular disease death rates that are two to five times higher than that of non-diabetic 
patients (ADA, 1994). Macrovasular diseases such as atherosclerosis and heart disease are 
diagnosed at an earlier age and with greater frequency in diabetic patients compared to 
nondiabetic patients (CDC, 1999). The risk of stroke is also two to five times greater in diabetic 
samples and 60 to 65% of individuals with diabetes have comorbid hypertension (CDC, 1999).  
Retinal neuropathy is also a common complication of diabetes. The CDC reports that diabetes is 
the leading cause of new cases of blindness in individuals from ages 20 to 74 years and is the 
leading cause of end-stage renal disease (CDC, 1999). Given the high rates of morbidity and 
mortality associated with poorly controlled diabetes, it is imperative that individuals with 
diabetes adhere to the treatment recommendations of their health care providers. 
Short-term studies of diabetic management in patients with Type 2 diabetes have 
demonstrated that when adherence to medical regimens is satisfactory, improvements in 
metabolic control, decreases in health risks, and decreases in complications result (Geraci et al., 
1999; Smith, Heckemeyer, Kratt, & Mason, 1997).  However, adherence to medical 
recommendations in diabetic patients is not the norm. A pervasive problem with adherence to 
medical regimens has been demonstrated for dietary control, regular exercise, glucose 
monitoring, and medication adherence (Bond & Hussar, 1991; Glasgow, 1991; Mason, 
Matsuyama, & Jue, 1993; Paes, Bakker, & Soe-Agnie, 1997; Skaer, Sclar, Markowski, & Won, 
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1993). A lack of adherence to medical regimens not only results in further health complications, 
as previously illustrated, but is also problematic for other reasons. Patients with poor metabolic 
control have higher utilization of the health care system. Previous research has demonstrated an 
increased number of clinic visits, hospital admissions, and emergency room visits by patients 
with poorly controlled diabetes compared to those with well-controlled diabetes (Bond & 
Hussar, 1991; Cowen, Jim, Boyd, & Gee, 1981). Further, poor metabolic control and adherence 
behaviors among diabetics are related to poorer levels of adjustment to their disease (Jacobson et 
al., 1990) and poorer quality of life (Weinger & Jacobson, 2001).     
Given the deleterious health, economic, and quality of life costs associated with non-
adherence, it is important for health care providers to use whatever resources are available to 
improve patient adherence. There is a critical need to identify variables that affect an individual's 
ability to maintain a diabetic regimen (Kavanagh, Gooley, & Wilson, 1993).  Because 
psychosocial factors are related to nearly every aspect of diabetes treatment, it may behoove 
health care providers to understand their influence on adherence behaviors.  
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REVIEW OF LITERATURE 
Health Locus of Control  
Health behavior theorists have attempted to explain how and why individuals engage in 
health risk behaviors or adopt healthy behaviors (Conner & Norman, 1996; Weinstein, 1993). 
Commonly, health behavior theories emphasize the importance of people’s perceptions as to 
whether they are in control of their health or not. In fact, most of the renowned theories of health 
behavior have in some way incorporated the construct of perceived control (Weinstein, 1993). 
For example, Ajzen’s (1975, 1980) Theory of Planned Behavior states that perceived behavioral 
control is one of three variables that strongly predict intentions to perform behaviors. The Health 
Belief Model discusses locus of control in terms of its direct impact on health behaviors (Becker, 
1974) and the “Goodness of Fit” hypothesis claims control as an integral part of the appraisal 
process of coping with stressors, which has an impact upon health behavior choices. Finally, and 
perhaps most importantly, Rotter (1966) originated the concept of ‘Locus of Control (LOC)’ in 
his Social Learning Theory.  
LOC has become a well-known construct in the realm of social-health psychology.  
Rotter coined the term ‘LOC’ and then developed a scale (i.e., the E-I scale) to measure the 
construct. At that time, he delineated two forms of LOC  (i.e., Internal vs. External) that could 
influence a person’s decision to perform behaviors. Rotter conceptualized LOC as a personality 
trait, positing that a person develops generalized expectancies, or perceptions of personal control, 
through experiences in a wide range of situations, and by adulthood, has stabilized these 
expectations (Rotter, 1954).  He defined an external LOC as the belief that outside forces (e.g., 
chance/luck, powerful others, God) were responsible for how things turned out in a certain 
situation.  Internal control was described as a belief that one has the ability to influence and 
change situational variables (Rotter, 1966).  
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Since the seminal works concerning LOC, there has been much debate regarding how it 
should be conceptualized and operationalized (Wallston, 2001). LOC is posited to vary based on 
context and has often been defined as ‘the belief that one can determine one’s own internal states 
and behavior, influence one’s environment, and/or bring about desired outcomes’ (Wallston, 
Wallston, Smith, & Dobbins, 1987, p. 5).  It is a construct heavily based on beliefs. Definitions 
have moved away from LOC denoting a stable personality style and the construct is now viewed 
in terms of its transient relationship to specific behaviors or situations. Perceptions of control can 
be accurate or inaccurate, but even if totally based on false perceptions, these perceptions can 
have a strong impact on behaviors and psychological outcomes (Rodin, 1990).   
Internal Health Locus of Control  
Research demonstrating the impact of health LOC on behavior has traditionally 
emphasized the importance of Internal Locus Of Control (ILOC) rather than external LOC.  
ILOC has been referred to as the pivotal interaction of health beliefs, heath behaviors, and health 
outcomes (Wallston, Wallston, & DeVellis, 1978; Wallston & Wallston, 1982; Wallston, 2001).  
For example, high levels of internal control beliefs have been linked with low levels of mortality 
and fewer activity limitations in medically ill patients (Seeman & Lewis, 1995). Further, 
Eizenman and colleagues (1998) found that an internal sense of control was linked to positive 
cognitive, psychological, and physical health outcomes in elderly adults (Eizenman, Nesselroade, 
Featherman, & Rowe, 1998). Similarly, Weaver and Gary (1996) linked low levels of internal 
control to decreased exercise and greater levels of depression in Black patients between the ages 
of 55-91 years. Finally, Van den Akker and colleagues (2001) recently conducted a longitudinal 
study with 3551 subjects and demonstrated that after adjusting for basic socio-demographic 
variables, high ILOC is even protective for the occurrence of morbidity (Van den Akker, 
Buntinx, Metsemakers, van der Aa, & Knottnerus, 2001). 
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Internal Locus of Control and Adherence Behaviors 
Adherence to medical regimens may be greatly affected by an ILOC. How well a patient 
adheres to a medical regimen depends, in part, on his or her beliefs and cognitions (Bandura, 
1997). Thus, the degree to which patients believe they can control health status or outcomes has 
an impact upon their motivation to perform self-care behaviors (e.g., exercise, diet, taking 
medications).  This relationship has been studied across a number of medical conditions. The 
common hypothesis has been that individuals with a greater endorsement of ILOC regarding 
their health status should have better health behaviors than do persons with less internal control 
beliefs. The rationale behind this theory stems from work suggesting that the perceived control 
over health may actually serve to promote mental and physical health (Cantor & Hunt, 1987; 
Taylor & Brown, 1988). Thus, researchers have speculated that individuals who feel in control of 
their health (i.e., those who have high ILOC) will take more respons ibility for their health and 
will be more likely to perform health behaviors suggested by health care providers than will 
individuals who do not feel in control of their health (i.e., those who have low ILOC). 
However, research on the influence of an ILOC on adherence behaviors has been 
somewhat disappointing (Maddux, Brawley, & Boykin, 1995; Wallston, 1992). Early studies 
found internally controlled patients to have better health behaviors such as seeking more 
information about their illness (Seeman & Evans, 1962; Wallston, Maides, & Wallston, 1976), 
greater success in weight loss programs (Balch & Ross, 1975; Kincey, 1981; Tobias & 
MacDonald, 1977), and greater success in smoking cessation programs (Schwebel & 
Kaemmerer, 1977; Strickland, 1978).  Over the years, however, other researches have not found 
ILOC to be consistently related to successful health behavior change, and reviews of the power 
of LOC to predict health behaviors have been generally pessimistic (Wallston, 1991; Wallston & 
Wallston, 1978; Wallston, Wallston, Smith, & Dobbins, 1989).  
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A similar contradictory trend can be found within the diabetes literature. Although some 
studies have shown perceived internal control to be associated with better adjustment to diabetes 
(Burns, Green, & Chase, 1986; Hamburg & Inoff, 1982; Helgeson & Franzen, 1998; Jacobson et 
al., 1990), better adherence to self-care regimens (Evans & Hughes, 1987; Jacobson et al., 1986), 
and better metabolic control (Brown, Kaslow, Sansbury, Meacham, & Culler, 1991; Konen, 
Summerson, & Dignan, 1993; Murphy, Thompson, & Morris, 1997; Reynaert et al., 1995; 
Stenstrom, Wikby, Andersson, & Ryden, 1998; Surgenor, Horn, Hudson, Lunt, & Tennent, 
2000), others have found opposite results.  Poorer adjustments to diabetes and poor metabolic 
control have been found among diabetic patients with high ILOC (Burns et al., 1986; Dunn, 
Smartt, Beeney, & Turtle, 1986; Edelstein & Linn, 1987; Evans & Hughes, 1987; Hamburg, & 
Inoff, 1982). Finally, some researchers have neglected to find a link between ILOC and 
outcomes in diabetic patients (Aikens, Wallander, Bell, & McNorton, 1994; Bunting & Coates, 
2000; Coates & Boore, 1995; Kneckt, Syrjala, & Knuuttila, 1999; Liakopoulou, Korvessi, & 
Dacou-Voutetakis, 1992; Ruzicki, 1984; Tillotson & Smith, 1996).  
Perceived Control Over Health: Beyond Internal Locus of Control 
Although researchers have speculated about the causes of the inconsistencies in the 
diabetic research and in other areas of research that have examined LOC, few have found 
answers. One reason may be that studies examining the construct of ‘control’ have simply 
examined ILOC to the exclusion of other constructs that may contribute to ‘control’ (Wallston, 
1992). Studies simply using a LOC scale to examine perceived control may not fully tap into or 
appreciate the construct’s multidimensionality. To examine the influence of perceived control on 
health behaviors, more than LOC may need to be measured.  Kenneth Wallston, an expert in the 
field of health behaviors and LOC, has argued that an LOC is only a portion of a larger and more 
important construct called ‘perceived control over health,’ which is related to health behaviors.  
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In fact, up until the past 10 years, definitions provided to define LOC have actually 
described something broader than LOC. This is evidenced by the definition of LOC provided 
earlier, which defined it as  ‘the belief that one can determine one’s own internal states and 
behavior (LOC), influence one’s environment (Self Efficacy), and/or bring about desired 
outcomes (Outcome Expectancy)’ (Wallston, Wallston, Smith, & Dobbins, 1987, p. 5). The two 
latter ideas described in this definition are the core variables in Bandura’s Social Cognitive 
Theory (1986). Once again, Wallston (1992) labels this larger construct, captured in this 
definition, as ‘perceived control over health.’  In an important review article, Wallston (1992) 
verbalized the need for LOC researchers to concurrently assess other types of perceived control 
constructs when investigating the relationship between control and health behaviors. 
Specifically, he has argued that LOC, along with Self-Efficacy and Outcome Expectancy, should 
be investigated because they are the important constructs that constitute perceived control over 
health (Wallston, 1992). By combining these three constructs, the result is an integration of two 
social learning theories to predict health behavior; one by Rotter (1966), which sparked the last 
30 years of work on health LOC, and one by Bandura (1986), which centers on Self Efficacy and 
Outcome Expectancy as the two primary determinants of health behavior.  This ‘revised social 
cognitive theory’ incorporating LOC, Self-Efficacy, and Outcome Expectancy has received 
negligible attention in the literature (Wallston, 1992; 2001).  
Differentiating Perceived Control Constructs 
Although the combination of the three control constructs has not been thoroughly studied, 
most researchers appreciate the difference between them. This is evidenced by the plethora of 
review articles and book chapters on perceived control that have outlined the three constructs 
separately, discussed their importance independently and interdependently, and have voiced a 
need for future research on the interaction of the three constructs (Rodin, 1990; Maddux et al., 
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1995; Talbot, Nouwen, Gingras, Gosselin, & Audet, 1997; Wallston, 2001). Collectively, health 
LOC is defined as the belief that one has control over one’s health. While Self Efficacy and 
Outcome Expectancy are also related to beliefs related to one’s health, they are quite distinct 
from LOC (Maddux et al., 1995; McCaul, Sandgren, O’Neill, & Hinsz, 1993; Rodin, 1990; 
Wallston, 1992).  Self Efficacy (SE) is defined as confidence that one can perform a particular 
behavior. A person who believes he is capable of performing a given behavior (e.g., following a 
diabetic diet) is more likely to perform that behavior (Bandura, 1997).  A person's SE for a given 
behavior is purported to dramatically affect his or her self-motivation for performing that 
behavior (Bandura, 1997). If a person feels capable of achieving a goal, then he is likely to work 
harder and give up less easily compared to a person who has low SE (DeVellis & DeVellis, 
2001). By these definitions, it should be clear that one’s LOC and SE are not necessarily related.  
For example, a person may believe he has control (ILOC) of his diabetes (e.g., he believes that 
his behaviors will affect his glycemic control), but may not feel confident (low SE) that he can 
perform the behaviors to control his blood sugar (e.g., eat a low fat diet, take medication, 
exercise daily).   
Outcome Expectancy (OE) must also be considered separately. OE is defined as the 
attitude that a behavior will produce a desired effect or, more within health behavior models, the 
belief that following medical regimen recommendations will actually result in improved health 
outcomes (Maddux et al., 1995; McCaul et al., 1993; Rodin, 1990; Wallston, 1992). Researchers 
have recently demonstrated the importance of expectations of behavioral outcomes (Anderson, 
Winett, & Wojcik, 2000; Hallam & Petosa, 1998; Morrill, Ickovics, Golubchikov, Beren, & 
Rodin, 1996). The sense that a behavior will result in desired outcomes, more so than actual 
outcomes, influences the likelihood that a behavior will be performed (Bandura, 1997).  
Although OE can be related to both LOC and SE (Bandura, 1977; Rodin, 1990), it may 
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contribute to behavior independently of LOC and SE (.Bandura, 1997; DeVellis & DeVellis, 
2001; Maddux et al., 1995). That is, a person may believe that he primarily controls or does not 
control his diabetes (ILOC), that he can adhere to his medical regimen if he desires (high SE), 
but may not perform the behaviors because he does not believe taking his medication, dieting, 
and exercising will result in glycemic control (low OE).  Thus, despite high ILOC and SE, low 
OE of health behaviors may contribute to poor adherence behaviors.  
Internal Locus of Control and Self Efficacy.  Independently, a number of studies have 
found a positive relationship between SE and adherence with medically recommended health 
behaviors (Bandura, 1997; Conn, 1998; Maddux et al., 1995; O’Leary, 1985). Greater SE is 
positively related to the promotion of health behaviors such as exercise (Brawley & Rodgers, 
1993; Kaplan, Atkins, & Reinsch, 1984; McAuley, 1991, 1994), smoking cessation (Bagozzi & 
Edwards, 1998; Haukkala, Uutela, Vartiainen, Mcalister, & Knekt, 2000), condom use (DiIorio, 
Dudley, Soet, Watkins, & Maibach, 2000; Fishbein et al., 2001; O’Leary, Goodhart, Jemmott, & 
Boccher-Lattimore, 1992), and breast self-examinations (Alagna, Morokoff, Bevett, & Reddy, 
1987; Rippetoe & Rogers, 1987). Previous research also suggests that high rates of SE enhances 
adherence to diabetic control regimens (Glasgow et al., 1989; McCaul, Glasgow, & Scha fer, 
1987); however, many of these studies have methodological problems (Maddux et al., 1995). 
One of the most serious mistakes repeatedly made is using OE scales to measure SE (Crabtree, 
1986; Grossman, Brink, & Hauser, 1987; Padgett, 1991).  On the other hand, some 
methodologically sound studies that have accurately measured SE have found it to be a good 
predictor of adherence with various aspects of a diabetic regimen (Glasgow et al., 1989; McCaul 
et al., 1987).   
Previous research with medical samples outside of diabetes has found an interaction 
between SE and LOC (Brownell & Cohen, 1995; McCaul et al., 1993; Ricker, Delamater, & 
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Hsu, 1998). For example, an internal perceived illness control and high SE has been linked to 
better dietary regimen adherence (Brownell & Cohen, 1995), regimen adherence in cystic 
fibrosis (Ricker et al., 1998), compliance with fluid regimens in patients end-stage renal disease 
(Schneider, Friend, Whitaker, & Wadhwa, 1991), pain tolerance (Litt, 1988), and adherence to 
exercise programs (Chen, Neufeld, Feely, & Skinner, 1999). Although there has been some 
support for the role of SE and ILOC in predicting medical regimen adherence in Type 1 diabetics 
(Glasgow, Toobert, Hampson, & Wilson, 1995; Talbot et al., 1997), this interaction has not been 
well researched with Type 2 diabetics.  Findings with other medical populations, dealing with 
similar behavior changes, suggest that there may be an interaction effect for ILOC and SE on 
adherence to diabetic regimens in Type 2 diabetics.   
Internal Locus of Control and Outcome Expectancy. OE has not received as much 
research attention as has SE.  The small amount of work that has systematically evaluated this 
variable has found OE to be positively related to health behaviors such as condom use (Morrill et 
al., 1996), nutritional behavior (Anderson et al., 2000), and exercise (Hallam & Petosa, 1998; 
Rodgers & Brawley, 1996). Also, unlike SE, the relationship between OE and adherence 
behaviors in diabetic patients has not been well established. Researchers have found outcome 
expectancies to predict compliance among diabetics (McCaul et al., 1987), but not as well as 
have SE or LOC (Maddux et al., 1995; Wallston, 1992). Finally, a link between OE and LOC has 
also not been well researched. Over the past few years, researchers have stressed the importance 
of differentiating between the two constructs, however, literature measuring both variables is 
scarce (Maddux et al., 1995). However, two studies within the pain literature demonstrated that a 
low ILOC is related to low OE among patients coping with pain (Melding, 1995; Wells, 1994). 
Although both of these studies were conducted in patients with chronic pain, not in diabetic 
patients, they have important findings; external health LOC related to pain is correlated with 
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weak beliefs that an intervention will produce a desired outcome. Extrapolating these findings to 
other health behaviors, it is hypothesized that external LOC would be related to poorer OE for 
adhering to medical treatment recommendations.  
Internal Health Locus of Control, Self-Efficacy, and Outcome Expectancy. Only a limited 
number of studies have examined moderators of ILOC and health behaviors (Wallston, 1992; 
Wallston, 2001), and there have been no studies to date that have conjointly examined the three 
most salient constructs of control (i.e., ILOC , SE, and OE) in relation to medical regimen 
adherence behaviors (Maddux et al., 1995; Wallston, 1992). Therefore, there has also been no 
work in this area among diabetic patients. The present study will be the first of its kind to 
perform an evaluation of these three constructs in relation to adherence behaviors and will do so 
in a diabetic population.   
In summary, it has been established that SE is positively related to adherence behaviors 
in diabetics. It has also been established that high SE is correlated with ILOC in relation to the 
adoption of health behaviors; however, this relationship has not been widely researched in 
diabetic populations. Further, although some limited research has linked high ratings of OE to 
better health behaviors, this construct has not received much attention regarding its relationship 
to diabetic adherence behaviors.  Finally, the interaction of OE and ILOC, and the relationship 
because ILOC, SE, and OE is scarce in the medical literature.   
External Health Loci of Control  
Another problem that is apparent when reviewing the health LOC literature related to 
adherence behavior is the neglect of external LOC (Mackenbach, Borsboom, Nusselder, 
Looman, & Schrijvers, 2001). External health LOC is the sense that one’s health outcomes or 
health status is reliant upon external forces. External health LOC has most often been assessed 
using the Multidimensional Health LOC (MHLC) scale, which will be discussed in detail later in 
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the present paper (Wallston, Stein, & Smith, 1994). This most recent version of this scale 
categorizes external LOC into 4 types of external beliefs; that God, health care providers, 
powerful others, or chance/fate influences health outcomes.  External LOC beliefs are not seen as 
mutually exclusive from each other or as diametrically opposed to ILOC. On the contrary, 
research has shown that individuals can have high LOC across a few different types of LOC 
(Peyrot & Rubin, 1994; Sensky & Petty, 1989; Stenstrom & Andersson, 2000; Wallston et al., 
1994; Wallston et al., 1999). Although the MHLC scale, and other scales, have been validated 
across numerous illnesses, studies focusing on health LOC often measure internal control to the 
exclusion of external control (Shapiro et al., 1996; Wallston, 1989).  This neglect is surprising 
given the long established validity of conceptualizing the construct of LOC as multidimensional 
and not simply unidimensional (Shapiro, Schwartz, & Astin, 1996).  It is also surprising because 
external LOC beliefs are commonly found amongst medical patients, particularly in the proposed 
study’s population (i.e., low-income). Some individuals are often prone to blaming external 
forces for their own poor health behaviors or outcomes (Oprendek & Malcarne, 1997; Perrig-
Chiello, Perrig, & Staehelin, 1999).  Further, previous research has demonstrated that low-
income, Black individuals with diabetes report significantly stronger external health LOC than 
do middle class, White, diabetic patients (Bell, Summerson, & Konen, 1995). Finally, patients 
with Type 2 diabetes, compared to Type 1 diabetes, report very strong perceptions of external 
control (Konen et al., 1993). For these reasons, external LOC should be considered, as should be 
ILOC , when investigating perceived control influences on adherence behaviors in low-income 
individuals with Type 2 diabetes.  
Studies investigating the role of a unidemensional construct of external LOC suggest it is 
related to poor health behaviors and deleterious outcomes in patients with chronic illness 
(Mackenbach et al., 2001). Patients with various chronic illnesses, with high external LOC , 
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report poorer physical functioning than do those with weaker external LOC (Mackenbach et al., 
2001). Further, diabetic patients with high external LOC endorsements have shown poor short-
term and long-term medical regimen adherence behaviors (Schwartz, Coulson, Toovey, Lyons, 
& Flaherty, 1991).  Finally, external beliefs have been linked to an increased development of 
health problems among healthy subjects (Van den Akker et al., 2001).   
A few trends have also been found in studies conceptualizing external LOC as 
multidimensional (i.e., chance, health care provider, powerful others, and God). The most 
consistent finding has been that a strong attitude that chance determines health outcomes is 
significantly correlated with poor health-related outcomes among diabetics, such as poor 
glycemic control (Peyrot & Rubin, 1994; Sensky & Petty, 1989; Stenstrom & Andersson, 2000) 
and irrational health beliefs (Christensen, Moran, & Wiebe, 1999). It has also been posited that 
adherence behaviors among diabetic patients are poor if patients have strong beliefs in the 
influence of powerful others on their health outcomes (Schlenk & Hart, 1984); however, unlike 
the influence of chance on health outcomes, this finding has not been replicated. Finally, 
research has shown that LOC in God over one’s health may be negatively correlated with 
adjustment to disease (Chaplin et al., 2001; Wallston et al., 1999), but not correlated to health 
behavior medical outcomes such as HbA1c. These findings should be interpreted with caution, 
given that research with the God scale is relatively new and has not been performed in different 
cultures such as southern Blacks. Before conclusions can be drawn about the relationship 
between God LOC and health behaviors, particularly within the Black culture, more research is 
needed.   
The intercorrelations of ILOC with the four primary external LOC beliefs has been 
examined in only a limited amount of studies with chronically ill populations (Wallston, Stein, & 
Smith, 1994; Chaplin et al., 2001; Wallston et al., 1999). ILOC is usually positively correlated 
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with health care provider beliefs (Wallston et al., 1994; 1999). If a patient has a strong sense that 
she controls her health, she is also more likely to believe her physician will have control over her 
health. Both ILOC and health care provider LOC, have been linked with positive health 
behaviors (Peyrot & Rubin, 1994; Sensky & Petty, 1989; Stenstrom & Andersson, 2000).  
Conversely, ILOC is usually negatively related to chance health LOC (Wallston et al., 1994; 
1999). In other words, individuals with a strong ILOC often report weak beliefs in the power of 
chance to control their health.  Finally, previous research has failed to demonstrate a positive or 
negative relationship between ILOC and the two other external scales (i.e., powerful others or 
God).  The present study will attempt to replicate these intercorrelations (Wallston et al., 1994; 
1999). 
Although the relationships between internal control and external LOC have been 
established, the interaction between external and internal beliefs has only been systematically 
examined in one study. Stenstrom and colleagues (1998) published a study that examined the 
interactions of internal locus of control beliefs with external beliefs and their relationship with 
diabetic adherence in Type 1 diabetic patients. The authors examined the interactions by 
artificially dichotomizing patients’ scores on the original MHLC; thus, each patient was either 
rated as high or low in ILOC, chance LOC, and healthcare providers LOC. The authors then 
categorized patients as one of eight possible combinations of LOC ratings.  Their results 
suggested that individuals who were high ILOC and low chance LOC had the best adherence to 
their diabetic regimen, as indicated by low HbA1c levels.  Although this study had novel and 
interesting findings, there were a few limitations to the investigation. First, the authors artificially 
dichotomized individuals’ LOC ratings. There are many problems with artificial dichotomy 
including the primary complaint that individuals who have scores in the center of the continuum 
are placed in the high or low category based on arbitrary guidelines. Another problem with this 
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study was that the authors do not provide demographic information regarding income level, 
education level, or racial characteristics of the sample. Finally, the MHLC scale only examined 
chance and powerful others LOC and did not investigate healthcare providers and God external 
LOC beliefs.  
The present study attempted to rectify these limitations found in the Stenstrom study by 
evaluating the interaction of internal and external LOC without artificially dichotomizing the 
data, sampling patients with specific demographic characteristics, and by using a LOC scale that 
queries healthcare provider and God LOC beliefs as well as chance and powerful others.  
The Assessment of Control Constructs 
 Patients’ perceptions of control, SE, and OE can be derived from various methods. To 
achieve a methodologically sound study, the present project used only standardized measurement 
tools. A wide range of assessment tools are available to choose from to measure ILOC, SE, and 
OE (Wallston, 1989). The following scales were chosen because they meet four criteria; 1) good 
psychometric properties, 2) used and validated in diabetic medical populations, 3) under a 5th 
grade reading level, and 4) disease specific for diabetes-related adherence behaviors (Bradley, 
1994).  The fourth criteria stems from research suggesting specificity is important in using 
measurement tools to predict behavior. Level of Specificity theory, developed by Ajzen and 
Fishbein (1980), posits that the degree of specificity in the measurement method should agree 
with the degree of specificity in the phenomenon of interest. Thus, when studying general health 
outcomes, a general measure should be used, whereas when measuring specific health outcomes 
(e.g., glycemic control in Type 2 diabetics), a specific assessment tool that taps into beliefs about 
controlling diabetes should be used (Kohlmann et al., 1993). Many researchers have argued that 
generalized control expectancies are of little use in predicting specific behavior outcomes 
                                                                                               
 17 
(Fishbein & Ajzen, 1985; Lefcourt, Martin, & Saleh, 1984). The following three scales were 
used to measure perceived control constructs related to diabetic regimen adherence.  
Internal and External Loci of Control  
LOC is most often conceptualized as an independent variable in psychological research 
and is often measured by paper and pencil scales (Wallston, 2001). Rotter’s original I-E scale 
was one of the most frequently used scales and was applied to many behaviors, including health 
behaviors (Wallston & Wallston, 1978); however, it was not until the first health LOC scale 
(HLC) was created by Wallston and colleagues (1976) that the impact of perceived illness 
control on health behaviors was truly appreciated. The original health LOC scale was designed to 
cover a wide range of health-related behaviors and health-related situations, which made it 
sometimes difficult to predict specific health behaviors (Wallston, Wallston, Kaplan, & Maides, 
1976). The original HLC scale was revised into the Multidimensional Health LOC (MHLC) 
scale because factor analyses demonstrated external LOC was multidimensional (Wallston et al., 
1994). Specifically, researchers demonstrated three distinct types of external health LOC 1) 
external-chance/fate, 2) external-powerful others, and 3) external-health care providers. Further, 
in the past few years, the same researchers added another 6 items to the MHLC scale that tapped 
into belief about God controlling one’s health outcomes (Wallston et al., 1999).  
The God LOC Scale was created because there is little known about how deferring to 
God or a higher being affects health behaviors (Wallston et al., 1999).  This is an important area 
to investigate because research shows that 94% of adults in the United States believe in God, 
90% pray to God, and a majority participates in religious practices (Park & Cohen, 1992). 
Though religious values seem to be pervasive throughout American culture, religiously based 
health beliefs have not received attention.  One reason for this insufficiency is a lack of 
measurement tools to study this construct. Recently, Wallston and colleagues (1999) developed 
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the first scale to measure religiously based health beliefs that could be applied to a specific 
disease state (Wallston et al., 1999). Because the authors of this scale are also the creators of the 
MHLC scale, it was designed to be used with the MHLC, form C. The God Health LOC (GHLC) 
scale measures the extent that an individual believes that God exerts control over a specific 
disease. It has been validated with two medical populations. Given the novelty of this scale, there 
has been no research published using this scale in conjunction with the MHLC in diabetic 
populations. Further, there has been limited research that has linked GHLC scores with medical 
outcomes such as indices of medical regimen adherence (e.g., HbA1C’s in diabetics) to 
determine the relationship between the scale and health behaviors. When used in its most recent 
form, the MHLC is now a 24- item scale, which is a disease-specific scale and consists of five 
subscales measuring internal and four types of external LOC (Wallston et al., 1994; Wallston et 
al., 1999). The MHLC is the most widely used scale to measure perceived health LOC and has 
been used across a wide range of medical populations, including diabetes (Bradley, 1994).  
Self-Efficacy 
The measurement of SE has received much attention in the past few years (DeVellis & 
DeVellis, 2001). SE is usually measured by asking people ‘how confident are you that you can 
do X behavior?’ Most responses are based on Likert scale options that indicate degree of 
confidence in ability to carry out a behavior. Like the measurement of similar constructs, 
avoidance of ambiguity, use of multiple rather than single indicators, and sensitivity to level of 
specificity is important when assessing SE (DeVellis & DeVellis, 2001; Maddux et al., 1995). 
Most recently, level of specificity has become a salient topic related to measuring SE. There has 
been a movement toward acknowledging that SE is not a unitary construct but an attribute that 
will vary within the same individual across many domains (DeVellis & DeVellis, 2001).  
                                                                                               
 19 
Therefore, it is important that SE be measured in correspondence with a specific behavior in 
mind and not in broad terms.     
Many researchers have followed Bandura’s original suggestions concerning how to 
accurately assess SE.  SE has been assessed across a wide range of behaviors (DeVellis & 
DeVellis, 2001) and many researchers have used scales created specifically for their research 
project. When available, however, it is prudent for researchers to use previously validated 
measurement tools. Recently a group of researchers developed and validated a 7- item scale to 
assess SE regarding adherence to diabetic regimens (Talbot et al., 1997), which was used in the 
present study. 
Outcome Expectancy   
OE refers to a person’s attitude that performing a certain behavior will result in a desired 
outcome. Although OE has been previously mistaken for LOC and SE (Devins et al., 1982), it is 
now accepted that the constructs are separate (DeVellis & DeVellis, 2001; Kirsch, 1995; 
MacLeod, 1999). Studies that have examined predictors of health behaviors have found LOC and 
OE to have unique contributions to models of behavior (Hofstetter, Sallis, & Hovell, 1990; 
Morrill et al., 1996; Ollendick & Schmidt, 1987).  Whereas an ILOC refers to whether 
individuals feels in control of their health outcomes, OE involves the feeling that performing 
certain health behaviors will actually result in a desired outcome. For example, a diabetic woman 
may believe that she is in control of her diabetes (high internal control), but not feel that 
performing the recommended health behaviors (e.g., eating right, exercising, taking medication) 
will result in better health. Conversely, another woman may not feel in control of her diabetes 
(low internal control), but have a positive OE that performing her diabetic care behaviors will 
result in better health.   
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In order to measure OE, a researcher must ask questions that tap into anticipated 
outcomes.  To accurately assess anticipated outcomes, questions regarding the importance of 
performing a behavior in relation to certain outcomes are often presented.  Although many 
researchers create their own scale to measure OE (Fishbein et al., 2001), recently a group of 
researchers created and validated a 6- item scale that assesses OE regarding adherence to diabetic 
regimens (Talbot et al., 1997) that was used in the present study.  
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PURPOSE OF STUDY 
Summary 
Patients with Type 2 diabetes often do not adhere to their treatment regimen (e.g., 
exercise, diet, medication, glucose monitoring) prescribed by their physicians. Inadequate 
adherence results in poor metabolic control, further morbidity and mortality, and increased health 
care utilization and costs. It is imperative to understand the contribution of various psychosocial 
factors to non-adherence in diabetic patients to promote better self-care. Health behavior models 
attempt to predict how certain variables will affect health behaviors and one common thread 
among theories is the importance of perceived control. The amount of control patients believe 
they have regarding illnesses [i.e., health locus of control (LOC)] can influence adherence to 
medical regimens. Although some research has investigated internal health locus of control 
(ILOC) in relation to medical treatment adherence in Type 2 diabetic patients, inconsistent 
findings have been reported.  These inconsistencies may be related to a need for further 
exploration of the interaction of ILOC with other perceived control constructs [i.e., self-efficacy 
(SE) and outcome expectancy (OE)], as well as with other external LOC constructs. Knowledge 
of the perceived control constructs, such as ILOC, SE, OE, and types of external LOC, and their 
influence on health related outcomes is important in that they may provide valuable information 
for clinical interventions, which may lead to better adherence and medical outcomes among Type 
2 diabetic patients. 
First, this study examined the relationship between ILOC, SE, and OE in relation to 
medical regimen adherence behaviors in low-income patients with Type 2 diabetes.  Further, the 
interactions of perceived control constructs with ILOC were evaluated. The two main constructs 
of Bandura’s Social-Cognitive theory, SE and OE, were expected to interact with ILOC to 
influence general diabetes adherence behaviors. SE has been linked to health behaviors in its 
                                                                                               
 22 
solidarity and in conjunction with ILOC, but this link has not been thoroughly researched in 
diabetic populations. Further, OE has also been positively linked with good health behaviors; 
however, research on this construct is scant in comparison to SE, and the interaction of OE and 
ILOC has not been examined in relation to adherence behaviors.  
This study also examined the influence of four types of external LOC, independently and 
when combined with ILOC, on medical regimen adherence behaviors in a sample of low-income 
patients with Type 2 diabetes. Most health LOC research has targeted internal control to the 
exclusion of external control influences. Previous research has demonstrated that external health 
LOC beliefs have been found among medical patients with chronic illnesses, particularly patients 
who are Black and those with Type 2 diabetes. Further, external LOC beliefs have been linked to 
poor adherence behavior among general medical patients. Specifically, a strong sense that chance 
impacts health outcomes is associated with poor adherence behaviors. The influences of other 
types of external health LOC (i.e., health care provider, powerful others, and God) on health 
behaviors have not been as well established in patients with Type 2 diabetes, and there has been 
only one previous investigation of the interaction of ILOC with external LOC beliefs in relation 
to medical regimen adherence behaviors.  
Finally, it should be noted that pervasive through the perceived control and adherence 
behavior literature is a lack of use of diabetes-specific scales. Instead, broadband scales asking 
questions about general health control perceptions (e.g., how much control do you feel you have 
over your health?) have been used. This is a salient issue because diabetes-specific scales are the 
most appropriate to use if one is targeting diabetes-specific outcomes (Ajzen & Fishbein, 1980). 
Also, throughout the literature there is little research on low-income, minority patients with 
diabetes, with research conclusions based on work with White, middle class individuals. Given 
that the majority of Type 2 diabetics in the United States are of low-income and Black, this is a 
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large oversight and research is needed that samples Blacks as well as individuals from various 
economic levels. The present study was the first to examine perceived control constructs in a 
low-income, predominantly minority, Type 2 diabetic population. It was also the first 
investigation to use the MHLC external scales, with the additional God subscale, in a low-
income population.  Finally, this was the first study to use the MHLC external scales, with the 
additional God subscale, in a Type 2 diabetic population. To answer the primary questions in this 
study, a biological marker, HbA1c, the gold standard of medical indicators for adherence 
behaviors among diabetic patients, was used to indicate gradations of medical regimen 
adherence. 
Research Questions and Hypotheses 
The following questions were addressed:  
Question 1. Are internal locus of control, self-efficacy, and outcome expectancy separate 
constructs?  
 
Hypotheses: Based on previous research, it was hypothesized that ILOC, SE, and OE are 
separate constructs. This was determined by examining the correlations between the three 
variables with stronger correlations (closer to 1) indicating more overlap between the 
constructs.  
Question 2. Type and strength of relationship between internal locus of control, self-efficacy, and 
outcome expectancy (see Table 1)?  
 
Hypotheses:  Based on previous research, it was hypothesized that ILOC would be 
positively, but moderately, correlated with greater ratings of SE and OE.  Further, it was 
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ILOC  SE  OE  
ILOC   + + 
SE   + 
OE    
+ = Positive correlation expected 
 
Question 3. Which variables (internal locus of control, self-efficacy, and outcome expectancy) 
are the best predictors of medical regimen adherence (HbA1c) in low-income patients with Type 
2 diabetes?  
 
Hypotheses: It was hypothesized that all three constructs would be related to HbA1c 
levels.  However, SE was expected to be the best predictor of HbA1c, with higher levels 
of SE related to better control of diabetes. ILOC was postulated to be the second 
strongest predictor, and OE to be the variable most weakly related to medical regimen 
adherence. 
Question 4. Do interactions of the three control variables contribute significant variance in 
predicting medical regimen adherence (HbA1c) beyond the main effects of the three constructs, 
in low-income patients with Type 2 diabetes?  
 
Hypotheses: It was expected that the interactions of the three constructs would account 
for additional significant variance beyond the variance accounted for by the main effects 
of ILOC, SE, and OE in predicting HbA1c. 
Question 5. Which of the six predictor variables, including interaction variables, accounts for the 
most variance in predicting HbA1c levels?  
 
Hypotheses: There have been no studies in the literature examining the interaction of 
ILOC, SE, and OE. Thus, a hypothesis could only be made based on theory and not on 
previous empirical support.  Based on theories that purport higher levels of ILOC beliefs 
(Rotter, 1966), as well as greater feelings of SE and OE, are related to better adherence 
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behaviors, it was posited that a three way interaction of high endorsements of ILOC, SE, 
and OE would be the strongest predictor of HbA1c.  
Question 6.  What is the type and strength of relationship between self-efficacy, outcome 
expectancy, and the four types of external loci of control?  
 
Hypotheses: It was expected that SE and OE would both be negatively correlated with 
chance LOC, God LOC, and powerful others LOC. However, based on previous research 
demonstrating that healthcare provider LOC is often positively related to ILOC and 
positive health behaviors, positive correlations were expected for SE, OE and healthcare 
provider LOC.  
Question 7. What is the type and strength of relationship between the five types of loci of control 
including internal, chance, powerful others, health care provider, and God (see Table 2)?   
 
Hypotheses: It was expected that the results for this study would be a replication of 
previous work that has examined the relationships between the five LOC subscales. Table 
2 illustrates the expected relationships between the five types of health LOC.   
Table 2: Hypothesized Relationships Between 5 Dimensions of Health LOC  





Internal  - + NC NC 
Chance   NC + + 
HCP    + NC 
PO     + 
God      
+ = positive correlation expected  
- = negative correlation expected 
NC = No correlation expected 
 
Question 8. Which of the five types of loci of control contribute the most variance to predicting 
medical regimen adherence (HbA1c)?  
 
Hypotheses: Based on previous literature, ILOC was expected to have the strongest 
relationship with HbA1c. Research has also shown that a strong belief in the power of 
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chance to influence health outcomes is related to adherence behaviors in diabetic patients. 
Therefore, chance LOC was expected to be the second strongest variable related to 
HbA1c levels. God LOC was expected to be the third strongest variable. Finally, external 
beliefs in health care providers were expected to have the fourth strongest influence and 
powerful other LOC would have the least influence on HbA1c.  
Question 9. Do the interactions of internal control beliefs with the four external loci of control 
scales contribute significant variance in predicting medical regimen adherence (HbA1c), beyond 
the main effects of the five loci of control independent variables?  
 
Hypotheses: The interactions of the internal control scale with the external control scales 
were expected to account for additional significant variance beyond the variance 
accounted for by the main effects. 
Question 10. Which predictor variables (i.e., internal, chance, powerful others, health care 
providers, God, internal x chance, internal x powerful others, internal x health care providers, and 
internal x God) accounts for the most variance in predicting HbA1c?  
 
Hypotheses:  The literature is not adequate to predict the interaction of the external scales 
with ILOC in relation to adherence behaviors in low-income Type 2 diabetic patients. 
Therefore, this analysis was predominantly exploratory in nature. However, as previously 
discussed, high ratings of chance LOC are related to poor adherence behaviors, whereas 
high ratings of ILOC are related to good adherence behaviors. Thus, it was hypothesized 
that the interaction of high ILOC and low chance LOC scores would account for the most 
variance in HbA1c compared to other predictor variables.  




 Participants for the present study were recruited from the Diabetes Disease Management 
Clinic at Earl K. Long Medical Center. This program consists of outpatient diabetes care 
management provided by a team of health care professionals, including a primary care physician, 
diabetes nurses, diabetes educators, and nutritionists. Patients who had been diagnosed with 
Type 2, non- insulin-dependent diabetes, prescribed medication to treat their diabetes, were 
attending a routine, 3-month, follow-up visit, and who were over the age of 18 years were 
recruited for this study. Only participants attending 3-month, routine visit were approached to 
participate. In order to attend a 3-month visit, patients must have had recent (past 2-3 months) 
blood work performed at the EKL Hospital blood laboratory. Patients were excluded if they were 
under the age of 18, had been diagnosed with Type I, insulin-dependent diabetes, did not have a 
recent (i.e., past 2 months) HbA1c level recorded in their medical chart, were not attending a 
standard, 3-month, follow-up visit, were not being treated pharmacologically, or if they could not 
orally comprehend at a 5th grade level as indicated by the Woodcock Johnson-Oral 
Comprehension test.   
Measures 
Demographic Questionnaire 
A demographic questionnaire was administered to all participants in order to collect the 
following information: name, hospital number, type of diabetes (I or II), time since diabetes 
diagnosis, date of birth, sex, marital status, age, race, and highest level of education completed.   
Woodcock Johnson- Oral Comprehension  
The Oral Comprehension section of the Woodcock-Johnson III –Test of Achievement 
(Woodcock, McGrew, & Mather 2001) was used to determine if participants’ comprehension 
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abilities were adequate to understand the questions contained in the study questionnaires. The 
Woodcock Johnson III is a standardized test of achievement that was revised in 2001. Oral 
comprehension is a subtest of the Woodcock Johnson that tests oral language.  Oral language is 
measured by the ability to comprehend a short passage and subsequently supply the missing 
word using syntactic and semantic cues. The oral cloze procedure requires the use of listening, 
reasoning, and vocabulary abilities. The test begins with simple analogies and associations and 
progresses to more complex passages. Oral Comprehension has a median reliability of .80 in the 
age range of 5 to 19 years and .89 in the adult range.  For the purposes of the present study, 
participants had to  demonstrate at least a 5th grade oral comprehension level. Patients were 
provided question items 1-13 and had to answer them correctly to demonstrate a 5th grade 
comprehension level. This cut-off was determined because the scales being used in the present 
study have a 5th grade reading level.  Patients who did not pass the comprehension test (n=3) 
were not included in the study and their participation was immediately terminated. However, 
they were still paid five dollars for their time.  
The Multidimensional Health Locus of Control Scale 
The Multidimensional Health LOC scale (MHLC-Form C; Wallston et al., 1994) was 
administered to the patients. This scale is a revised version of the original MHLC scale by 
Wallston, Wallston, & Devillis (1978). This MHLC consists of 18 items and taps into beliefs that 
the patient controls his or her own health. Responses are based on a 6-point Likert scale with 
answers ranging from 1=strongly disagree to 6=strongly agree.  The internal and external/chance 
subscales consist of 6 items and scores range from 6 to 36, with greater scores indicating 
stronger belief in the specific LOC. The external/powerful others and external/health care 
providers subscales consist of three items with scores ranging from 3 to 18, with higher scores 
indicating stronger belief in that type of LOC.  The scale has adequate internal consistency with 
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cronbach alphas ranging from .70 to .87 (internal = .87; chance = .82; powerful others = .70; 
health care providers = .71). Research with this scale has also demonstrated adequate test-retest 
reliability (r = .80) and good concurrent validity with other measures of health LOC (r = .59). 
This scale has been adapted for various specific diseases including diabetes (Wallston et al., 
1994), which was used in the present study.   
The God LOC Scale (GLHC - Wallston et al., 1999) was developed to assess the extent 
of an individual’s belief that God controls his or her health status. The GLHC consists of 6 items 
and was created to be used along with the MHLC scale, Form C; thus it is a disease-specific 
scale. Responses are based on a 6-point Likert scale ranging from 1=strongly disagree to 
6=strongly agree.  Total raw scores range from 6 to 36, with higher scores indicating greater 
endorsement that God controls health outcomes. Initial studies have demonstrated good 
reliability and va lidity in patients with various chronic illnesses such as rheumatoid arthritis 
(Wallston et al., 1999). Internal consistency estimates for the scale ranged between .87 and .94. 
The GLHC scale was compared to the four other subscales of the MHLC and results indicate 
adequate independence of the five total scales.  Recently published data supports the contention 
that the GLHC scale accounts for additional variance that the other MHLC subscales do not 
measure (Chaplin et al., 2001).  The authors of the GLHC scale suggest integrating the 6 items of 
the scale into the 18- item, Form C, MHLC scale, which creates a final LOC scale that is 24 items 
in length (Wallston et al., 1999).  
The Multidimensional Diabetes Questionnaire 
The Multidimensional Diabetes Questionna ire (MDQ; Talbot et al., 1997) is a scale 
designed to assess diabetes-related social and cognitive factors. The questionnaire consists of 
three subsections that measure 1) perceptions of diabetes and related social support, 2) positive 
and misguided reinforcing behaviors related to self-care activities, and 3) SE and OE related to 
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diabetic treatment. Although the MDQ in its entirety was administered for the present study, only 
section three of the MDQ (SE and OE subscales) was used to answer the present research 
questions. The SE scale is comprised of 7 items and measures patients’ confidence in their ability 
to perform behaviors specific to diabetes self-care activities (diet, exercise, medication, blood 
glucose monitoring, and general diabetes management). Responses are based on a scale of 0 (not 
at all confident) to 100 (very confident).  This scale possesses good internal consistency 
(cronbach alpha = .89) and has adequate external validity in relation to self-report adherence 
behaviors such as diet (r = .58), exercise (r =.48), and HbA1c levels (r =.28) among diabetic 
patients.   
The OE scale is 6 items and assesses patients’ perceptions of the effects of diabetes self-
care behaviors on metabolic control and the prevention of complications. Responses are based on 
a scale of 0 (not at all important) to 100 (very important). The OE scale is also internally 
consistent (cronbach alpha =.86) and is significantly correlated with diet (r = .23) and exercise (r 
=.33) behaviors among diabetic patients, though not as strongly as is SE. Finally, correlations 
between SE and OE scales were low to moderate, indicating they can be accurately 
conceptualized as distinct but somewhat correlated dimensions (Talbot et al., 1997).    
Biological Marker of Medical Regimen Adherence – HbA1c 
Adherence to medical regimen in diabetics was measured by the patient’s metabolic 
control, which was determined by glycosylated hemoglobin levels. Glycosylated hemoglobin, or 
HbA1c, is a biological marker that reflects blood glucose levels over the previous 2-3 months 
(Gonen, Rubenstein, Rochman, Tanega, & Horwitz, 1977).  Hemoglobin is the main component 
of red blood cells and is a protein that carries oxygen in the blood system (Porte & Sherwin, 
1997). When a diabetic patient’s blood sugar becomes elevated, the glucose adheres to the 
hemoglobin, resulting in glycosylated hemoglobin or HbA1c.  The new hemoglobin, with 
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attached glucose, is permanent and easy to detect with blood tests (Porte & Sherwin, 1997). A 
laboratory technique called electrophoresis is performed on blood draws from patients with 
diabetes. This test separates HbA1c from normal hemoglobin (Porte & Sherwin, 1997).  Medical 
regimen adherence, or glycemic control, over the past 2 to 3 months is indicated by the 
percentage of HbA1c present compared to normal hemoglobin. These percentages indicate how 
much hemoglobin has been altered as a result of high blood sugar levels over the past 2 to 3 
months. HbA1c levels can only predict glycemic control for the previous 2 to 3 months because 
the average life span of hemoglobin is approximately 90 days. After 90 days, most hemoglobin 
will die and new hemoglobin will be formed (Porte & Sherwin, 1997). Thus, if a patient adheres 
to the medical recommendations and the glucose remains in relative control for 90 days, there 
will be very low levels of HbA1c in the blood (Porte & Sherwin, 1997).  This test for HbA1c is 
considered an accurate indicator of long-term blood glucose control (Gonen et al., 1977). 
The normal range of HbA1c in individuals without diabetes is between 4 – 6 %. A person 
with diabetes with HbA1c between 4 – 7 % is considered to have good metabolic control; thus 
good adherence to the diabetic regimen. Results greater than 8% are considered poor or 
subnormal control (Kavanagh et al., 1993). Finally, 12% and above is considered very poor 
control (Porte & Sherwin, 1997).  
The present researcher collected preliminary pilot data from EKL hospital’s internal 
medicine clinic. A list of HbA1c levels from 1218 Type 2 diabetic patients who attended EKL 
primary care clinics, and who were on pharmacological agents over the past 12 months, was 
compiled. Results suggest that out of 1218 patients, 742 (61%) individuals had HbA1c levels 
under 8% and were considered ‘controlled’ by their primary care physician at EKL hospital. The 
remaining 476 (39%) had HbA1c levels greater than 8%, and thus were labeled uncontrolled 
diabetics by their primary care physician at EKL hospital. Finally, HbA1c levels range in the 
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present diabetic population from below 7% to greater than 12%. HbA1c was treated as a 
continuous variable in the present study.  
Procedure 
The primary investigator and two research assistants who were also clinical psychology 
graduate students collected data from the Internal Medicine and Family Practice clinics at EKL 
Hospital. The two diabetic clinics’ daily appointment lists were reviewed briefly to determine 
which patients were attending 3-month follow up visits. Patients meeting the inclusion criteria of 
attending follow up visits were approached in the waiting room of the clinics. If the patient was 
over 18 years of age, the researcher informed the patients about the nature of the study, time 
commitment, and monetary compensation that would occur if they were eligible for the study. If 
patients agreed to participate, they were asked to meet the researcher in the waiting room at the 
completion of their medical appointments. After their medical appointments were completed 
participants were asked to provide informed consent. All participants were told that the present 
study was designed to examine the impact of perceptions of health control on adherence of 
medical regimens in Type 2 diabetic patients. The researcher explained the inclusion criteria to 
the participants and informed them that if they failed to meet any of the inclusion criteria (e.g., 
the oral comprehension requirement), their participation would be terminated. Further, the 
researcher explained limits of confidentiality.  Participants were also informed that their medical 
chart would be examined and HbA1c levels extracted if they agreed to participate. Finally, 
participants were told that they had the right to withdraw from the study at any time without 
penalty, and were able to refuse participation with no risk for detrimental consequences on their 
medical care. Patients were provided with a copy of the informed consent packet, which 
contained the researchers’ contact information.  
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After consent was given, participants were briefly interviewed and the oral 
comprehension portion of the Woodcock Johnson-III was administered.  For the purposes of the 
present study, participants had to demonstrate at least a 5th grade oral comprehension level by 
answering items 1-13 correctly on the comprehension test.  This cut-off was determined because 
the scales being used in the study have a 5th grade reading level. Patients who did not pass the 
comprehension test (n=3) were not included in the study and their participation was immediately 
terminated; however they were still provided five dollars for their time. Patients who 
demonstrated a 5th grade oral comprehension level went on to complete the other three self-
report scales. After the data were collected, the researcher queried the patient about their 
impressions of the study and provided ample time for the patients to discuss or ask questions 
about medical regimen adherence and living with Type 2 diabetes. The patients were then paid 
five dollars and were free to leave the hospital. Finally, the researcher reviewed the patients’ 
medical charts and recorded the most recent HbA1c level.     
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RESULTS  
Descriptive and Frequencies 
Demographic Characteristics  
One hundred and thirty three patients were approached to participate in the present study. 
Out of these patients, 8 people refused to participate, 3 did not pass the oral comprehension 
section of the Woodcock Johnson, and only 13 did not have recent blood work recorded in their 
medical chart. A total of 109 patients participated in the study.  Out of these 109 participants, 
26% were male (n=28) and 74% were female (n=81). The average age of the patients was 52 
years old (SD = 11.16) and the average years of formal education was 11.5 years (SD = 2.2). 
Seventy four percent of the participants were Black (n=81), while 26% were White (n=28). 
Twenty nine percent were single (n=32), 38% were married (n=41), 21% were separated or 
divorced (n=22), and 13% were widowed.   
Patient report, a review of the medical charts, as well as physician corroboration, 
confirmed the following data regarding patient medical information: All patients who 
participated in this study were diagnosed for at least one year with Type 2 diabetes mellitus; the 
average time since diagnosis was approximately 8 years (SD=7.25); 100% were taking 
medication.  Finally, the mean HbA1c level for the present sample was 8.31 (SD=7.27), with 
reported levels ranging from 4.9 to 15.1 (see Table 7).  
Pearson Product Moment Correlations were performed to determine the relationships 
between the three continuous demographic variables (i.e., age, time since diagnosis, and 
education level) and the psychological constructs used in the present study (i.e., self efficacy, 
outcome expectancy, ILOC, God, chance, healthcare providers, and powerful others LOC).  
Pearson r product moment correlations are presented in Table 3. Age was only significantly 
correlated with SE. The relationship was positive suggesting that older age is related to greater 
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confidence that one can follow a diabetic medical regimen (i.e., diet, exercise, medication, 
glucose monitoring). Time since diagnosis was not related to any of the psychological constructs; 
however, education level was meaningfully related to two of the external LOC scales. External 
chance and powerful others LOC was negatively correlated with education level indicating tha t 
as education level increases, beliefs that chance and other people control health or diabetes 
decreases.   
Table 3 
 
Intercorrelations Between Continuous Demographic Variables and Self-Efficacy,  
Outcome Expectancy, and Five Loci of Control Scales 
          Scales 
Demographic    SE OE  ILOC     God      Chance      HCP   PO  
Variable 
 
1.Age    .24*  .13   .14      -.01  -.04 .12 .06 
 
2.Time 
Since Dx  -.15     -.13  -.10       .10  -.01 .11 .05 
 
3.Education  -.13 .08   .04      -.16  -.27**  .03     -.24* 
 
** p < .01 level 
* p < .05 level  
 
Independent t-tests were performed to determine if race or gender differences existed for 
SE, OE, or the five types of LOC (i.e., internal, God, chance, healthcare providers, and powerful 
others). Gender (see table 4) differences in SE, OE, or LOC beliefs were not found.  However, 
racial differences were found; though only one difference was significant at a .05 alpha level.  A 
significant difference was found between Blacks and Whites concerning their belief that God is 
in control of their diabetes (see Table 5). The means indicate that Blacks have a stronger belief in 
God LOC than Whites in this sample.  
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Finally, multivariate analyses of variance (MANOVAs) were performed to determine if 
marital status was significantly related to SE, OE, or the five types of LOC (i.e., internal, God, 
Table 4 
Gender Differences in Mean Ratings of Self-Efficacy, Outcome Expectancy,  
and Loci of Control   
Scale     Means (SD)         T-Test Results 
                                     Male (n= 28) Female (n= 81)   t (107)  p 
1. SE  66.71(22.95) 67.50(21.50)   -.16  .87  
 
2. OE  92.53(10.15) 92.35(13.73)   .06  .95 
 
3. ILOC  4.61(1.18) 4.52(.98)   .38  .71 
 
4. God  3.21(1.28) 3.02(1.37)   .64  .52 
 
5. Chance 2.54(.82) 2.48(1.09)   .24  .81 
 
6. Healthcare  5.17(.88) 5.01(.85)   .82  .42 
 
7. Pow. Others 2.56(1.26) 2.43(1.09)   .53  .60 
 
** p < .01 level 
* p < .05 level 
Table 5 
 
Racial Differences in Mean Ratings of Self-Efficacy, Outcome Expectancy,  
and Loci of Control   
Scale     Means (SD)    T-Test Results   
   Black (n=81) White (n=28)    t (107)  p  
1. SE   69.32(22.03) 61.48(20.27)   1.65  .10 
 
2. OE   92.13(13.93) 93.18(9.29)   -.37  .71 
 
3. ILOC  4.45(1.05) 4.82(.97)   -1.66  .09 
 
4. God   3.21(1.33) 2.64(1.32)   1.96  .05* 
 
5. Chance  2.57(1.02) 2.27(1.04)   1.37  .18 
 
6. Healthcare   4.96(.87) 5.31(.80)   -1.86  .06 
 
7. Pow. Others 2.42(1.17) 2.58(1.02)   -.66  .51 
* p < .05 level 
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chance, healthcare providers, and powerful others).  Significant differences were not found for 
SE (F(3, 108) = 1.20, p=.32), OE (F(3, 108) = 1.31, p=.28), ILOC (F (3, 108) = 1.07,  p=.36), 
God (F (3, 108) = .40, p=.75), chance F(3, 108) = .10, p=96), healthcare providers (F(3, 108) = 
.67, p=.57), or powerful others (F (3, 108) = .31, p=.82, LOC).  
Preliminary Analyses  
Pearson produc t moment correlations were performed to determine if any of the 
continuous demographic variables were significantly correlated with the dependent variable (i.e., 
HbA1c). Results showed that HbA1c was not significantly correlated with time since diagnosis (r 
=.11, p = .27) or education level (r = .06, p = .52).  However, age  was significantly, negatively 
correlated with HbA1c (r = -.36, p < .0001); older patients were more likely to have lower 
HbA1c levels, indicating better adherence to their medical regimens (see Table 6).  Age was also 
meaningfully related to education level and time since diagnosis in that older age was related to 
less time since diagnosis and lower education level. That is, patients who were older were more 
likely to have lower HbA1c levels, to have been diagnosed for shorter periods of time, and to 
have lower education levels.  
Next, independent t-tests were performed to determine if categorical demographic 
variables were meaningfully related to HbA1c. HbA1c was not significantly related to sex t 
(107) =.71, p=.48, or race t (107) = 1.95, p=.06.  Finally, an Analysis of Variance (ANOVA) was 
conducted to test differences if HbA1c levels differed significantly based on marital status. 
Results were not significant F (3, 108) = .146, p=.93. Means and standard deviations were 
calculated for the 5 health LOC subscales (i.e., internal, god, chance, powerful others, and 
healthcare providers), SE, and OE. Please see Table 7 for means and standard deviations of these 
psychological variables. 
For the each of the health LOC scales, higher scores indicate greater feelings that  




Intercorrelations Between Age, Time Since Diagnosis, Education, and HbA1c  
 Variable    1  2  3  4 
Patients (N=109) 
1. Age    --  .24*  -.22*  -.36** 
2. Time Since Dx    --  -.12   .10 
3. Education       --   .06 
4. HbA1c           --_____ 
** p < .01 level 
* p < .05 level  
 
Table 7 
Descriptive Statistics for HbA1c, Self-Efficacy, Outcome Expectancy, and Five Locus of Control 
Scales  
 
Variable     Mean (SD)    Minimum Maximum 
1. HbA1c    8.38 (7.27)            4.9  15.1   
2. SE    67.29 (21.77)    15 (0) 100 (100) 
3. OE    92.40 (12.85)    23 (0) 100 (100) 
4. Healthcare Providers LOC 5.05 (.86)    2 (1)  6 (6) 
5. ILOC    4.54 (1.04)    1 (1)  6 (6)   
6. God LOC   3.07 (1.34)    1 (1)  6 (6) 
7. Chance LOC   2.50 (1.03)    1 (1)  5 (6) 
8. Powerful Others LOC  2.46 (1.13)    1 (1)  6 (6) 
 
diabetes is controlled by said subscale (see Table 7). For example, higher averages for the God 
subscale (i.e., 5.5) indicates that patients strongly believe that God controls their diabetes and if 
they get better or worse physically. In Table 7, the health LOC subscales are presented in rank 
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order of highest averages (i.e., health care providers) to lowest averages (i.e., powerful others). 
Higher scores for SE indicates greater confidence for performing health behavior 
recommendations to manage diabetes. Finally, higher scores for the OE variable indicates 
stronger attitudes that performing the health behavior recommendations prescribed by their 
physicians will actually result in diabetic control and decreased health complications.  
Primary Analyses  
For all the following regression analyses an apriori acceptance p value <.01 was used. 
This value was chosen instead of a .05 acceptance value to decrease the likelihood of Type I 
error, since there were many analyses performed to answer the research questions. Further, for 
all regression analyses, age was statistically controlled due to its significant relationship with the 
criterion variable, HbA1c.  
Question 1. Are internal locus of control, self-efficacy, and outcome expectancy separate 
constructs?  
Pearson Product-Moment Correlations were performed to determine the relationships 
between ILOC, SE, and OE. As Table 8 illustrates, hypothesis one that the three variables are 
separate constructs was supported.  
Question 2. Type and strength of relationship between internal locus of control, self-efficacy, and 
outcome expectancy?  
 
Hypothesis 2 that the three constructs would be significantly, positively, but moderately 
correlated, was also supported (see Table 8). This is congruent with previous research that has 
found average correlations between ILOC, SE, and OE to range between .30 and .50 (Talbot et 
al., 1997).   
A simultaneous multiple regression analysis was performed with HbA1c as the criterion 
variable and ILOC, SE, and OE as the predictor variables. Age was controlled for in this analysis 
and accounted for 11% of the variance found in the model and had a -.27 partial correlation 
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Table 8 
Intercorrelations Between Internal Locus of Control, Self-Efficacy, and Outcome  
Expectancy  
 
Scale      1  2  3  4  
Patients (N=109) 
1. ILOC       --           .27*             .25    -.20* 
 
2. SE      --  .31*  -.44* 
 
3. OE          --  -.13 
 
4. HbA1c          -- 
 
* p < .01 level 
 
Question 3. Which variables (internal locus of control, self-efficacy, and outcome expectancy) 
are the best predictors of medical regimen adherence (HbA1c) in low-income patients with Type 
2 diabetes?  
 
coefficient with the criterion variable. The regression model was significant R = .52; R2 = .27; 
SE = 2.06 with the R2 indicating that the combination of the three variables accounts for 27% of 
the variance of HbA1c levels in this sample. Also, the partial correlation coefficients and the 
Beta values (see Table 9) indicate that SE had the strongest relationship with HbA1c levels, 
which is consistent with our hypothesis for question three. ILOC had the second strongest 
relationship with HbA1c and OE had the weakest relationship with HbA1c (see Figure 1). 
     Partial = -.09 
 
     Partial = -.37 
 
     Partial = .04 
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Table 9  
Summary of Simultaneous Regression Analysis for Perceived Control Variables  
Predicting Adherence to Medical Regimens (i.e., HbA1C levels) (N=109) 
 
 Variable   B SE  Beta   Partial    
 
ILOC   -.18 .20  -.08  -.09 
 
SE*   -3.98 .01  -.37  -.37  
 
OE    6.63 .02   .04   .04 
 
Note: R = .52; R2 = .27; SE = 2.06 (p < .01).  
* p < .01 level 
 
Question 4. Do interactions of the three control variables contribute significant variance in 
predicting medical regimen adherence (HbA1c) beyond the main effects of the three constructs, 
in low-income patients with Type 2 diabetes?  
 
 In order to examine the interaction of the three perceived control variables and their 
relationships with HbA1c, the interaction variables had to be created. First, the three perceived 
control variables were standardized, or centered, into Z scores, as recommended by Aiken and 
West (1991). ‘Considerable multicolinearity can be introduced into a regression equation with an 
interaction when the variables are not centered…centering predictor variables will often help 
minimize these problems’ (Aiken & West, 1991, pp. 34-35). Next, the centered perceived control 
variables were multiplied by each other to create the following 3 interaction variables; 1) ILOC 
X SE, 2) ILOC X OE, and 3) ILOC X SE X OE.  Table 10 illustrates the intercorrelations 
between the 6 variables.    
A hierarchical multiple regression consisting of two blocks was then performed to 
determine if the interaction variables accounted for a significant variance in predicting HbA1c 
levels, above the main effects of the three perceived control variables. For this regression, 
HbA1c was the criterion variable and the first block entered consisted of ILOC, SE, and OE. The 
second block entered consisted of the three interaction variables.  Age was controlled for in this 




Intercorrelations Between Internal Locus of Control, Self-Efficacy, and Outcome  
Expectancy and Their Interaction Variables 
 
Scale                     1   2  3  4            5  6            
Patients (N=109) 
 
1. ILOC      -- .27       .26 -.31 -.25 .35   
 
2. SE    -- .31 -.21 -.21 .32   
 
3. OE      -- -.22 -.55 .47    
 
4. ILOC X SE      -- .37 -.36 
 
5. ILOC X OE        -- -.64 
 
6. ILOC X SE X OE             --    
 
 
analysis and accounted for 11% of the variance found in the model and had a -.27 partial 
correlation coefficient with the criterion variable. As evidenced in Table 11, the R2 change of 6% 
from step one to step two was significant. The hypothesis that the interaction variables would 
account for additional variance was supported (see Figure 2). However, the interaction of ILOC 
x OE was the only significant interaction suggesting that this variable is accounting for the 
additional variance that is accounted for by adding the interaction variables. This was not 
consistent with the present researcher’s hypothesis that the three-way interaction would account  
for the additional variance.  Further, partial correlation coefficients indicate that self efficacy 
shared 37% of its variance with HbA1c, suggesting it is the strongest predictor of medical 
regimen adherence. However, the interaction of ILOC and OE was also significant and its partial 
correlation coefficient was .24 suggesting the interaction of these two variables shares a 
moderately strong relationship with HbA1c (see Figure 2).  
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Figure 2: Additional Variance Accounted for by Perceived Control Interaction Variables in 
Predicting HbA1c 
 
Question 5. Which of the six predictor variables, including interaction variables, accounts for the 
most variance in predicting HbA1c levels?  
 
A forward multiple regression analysis was performed to answer question 5. For this 
analysis, HbA1c level was used as the criterion variable and the predictor variables were 1) 
ILOC, 2) SE, 3) OE, 4) ILOC x SE, 5) ILOC x OE, and 6) ILOC x SE x OE, which were entered 
in this respective order. Age was controlled for in this analysis and accounted for 11% of the 
variance found in the model and had a -.27 partial correlation coefficient with the criterion 
variable. The overall model was significant and accounted for 24% of the va riance in predicting 
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Summary of Hierarchical Regression Analysis for Perceived Control Variables  
Predicting Adherence to Medical Regimens (i.e., HbA1C levels) (N=109) 
 
 Variable        B     SE  Beta  Partial 
 
Step 1  
ILOC    -.18 .20  -.08  -.09 
 
SE*    -3.98 .01  -.37  -.37  
 




ILOC    -.10 .21  -.04  -.05  
 
SE*     -.86 .22   -.36  -.37 
 
OE     .43 .24  .18  .17 
 
ILOC X SE   3.32 .18  .02  .02   
 
ILOC X OE*   .53 .22  .29  -.24    
 
ILOC X SE X OE         1.20 .15  .01  .01 
Note: R = .52, R2 = .27, SE = 2.06 (p < .01) for Step 1;  
Note: R = .57, R2 = .33, SE = 2.01 (p < .01) for Step 2;  
Note:  ∆ R2 =  .06 from Step 1 to Step 2 (p < .01).  
* p < .01 level 
 
and the interaction of ILOC and OE were the only two variables with a significant relationship to 
HbA1c. ILOC, OE, ILOC x SE, and ILOC x SE x OE were all excluded from the model (see 
Figure 3).   
Beta values indicated the strength of the relationship between each predictor variable and 
HbA1c, with the other variables in the regression controlled for. Self-efficacy shared the greatest 
amount of unique variance with HbA1c (-.36), while the interaction of ILOC x OE shared the 
second greatest amount of unique variance with HbA1c (-.23).  Thus, the answer to question 5 
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    Partial = -.36 
 
 
   Partial = -.23 
Figure 3: Self-Efficacy and Interaction of Internal Locus of Control and Outcome Expectancy in 
Predicting HbA1c 
 
was that SE is the strongest predictor of medical regimen adherence. Further, the only interaction 
variable that was related to HbA1c was the interaction of ILOC x OE.  An evaluation of the raw 
data as well as the Scatterplot graphs (Aiken & West, 1991) demonstrated the direction of the 
interaction of these two variables and its relationship with HbA1c (see Figure 4).  Results 
suggest that when high ratings of ILOC interact with concurrent strong feelings of OE, 
individuals are more likely to have lower HbA1c levels.  In other words, individuals with 
concordant higher ratings of ILOC and OE were likely to be more adherent to their diabetic 
regimen, as evidenced by lower HbA1c levels.  
Question 6.  What is the type and strength of relationship between self-efficacy, outcome 
expectancy, and the four types of external loci of control?  
 
Pearson Product-Moment Correlations were performed to determine the intercorrelations 
between SE, OE, and the four external LOC subscales (i.e., God, chance, healthcare provider, 
and powerful others). Results suggest that although SE and OE were negatively correlated with 
chance, God, and powerful others LOC, and were positively correlated with healthcare provider 
LOC, the correlations were weak and not statistically significant.  
Question 7. What is the type and strength of relationship between the five types of loci of control 
including internal, chance, powerful others, health care provider, and God?   
 
Pearson Product Moment Correlations were performed on the five types of LOC. As 
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Summary of Forward Multiple Regression Analysis for Perceived Control Variables Predicting 
Adherence to Medical Regimens (i.e., HbA1C levels) (N=109) 
 
Variables Included in Model  B  SE  Beta  Partial 
SE*      -.80 .20  -.34  -.36 
 
ILOC X OE*      .37 .16  .20  -.23   
_____________________________________________________________________ 
Note: R = .55; R2 = .30; SE = 2.00 (p < .01). 
*p < .01 level 
 
healthcare provider LOC. ILOC was significantly correlated with both of these external LOC 
scales but in different directions (see Table 14). ILOC was negatively correlated with God LOC 
and positively correlated with healthcare provider LOC. God LOC was significantly, positively 
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related to the powerful others and chance subscale scores. Finally, chance LOC was significantly 
and positively related to powerful others LOC.   
Table 13  
 
Intercorrelations Between Self-Efficacy, Outcome Expectancy, and External Locus of  
Control Scales 
Scale     Chance God  PO  HCP 
Patients (N=109) 
SE   -.01  -.07  -.07  .14   
 
OE    -.07  -.12  -.15  .12  
 
* p < .01 level 
 
Question 8. Which of the five types of loci of control contribute the most variance to predicting 
medical regimen adherence (HbA1c)?  
 
A simultaneous multiple regression was performed in order to answer question 8 
regarding which of the five types of locus of control is the strongest predictor of HbA1c level. 
Once again, HbA1c was the criterion variable while ILOC, God, chance, healthcare provider, 
and powerful others LOC were the predictor variables (see Table 15). Age was controlled for in  
this analysis and accounted for 13% of the variance found in the model and had a -.37 partial 
correlation coefficient with the criterion variable. This model was not significant, R = .41; R2 = 
.17; SE = 2.21, and the R2 showed that only 17% of the variance of HbA1c levels in our sample 
could be explained by ratings on the five LOC scales. Further, only age, the confounding 
variable, was significant in the model, while none of the 5 loci of control variables were 
significant.   
Question 9. Do the interactions of internal control beliefs with the four external loci of control 
scales contribute significant variance in predicting medical regimen adherence (HbA1c), beyond 
the main effects of the five loci of control independent variables?  
 
In order to examine the interaction of the locus of control variables the variables were 
standardized, or centered, into Z scores, as recommended by Aiken and West (1991). Next, the 




Intercorrelations Between Internal, God, Chance, Healthcare Provider, and Powerful  
Others Loci of Control  
 
Scale        1        2           3   4    5   6 
Patients (N=109) 
 
1. ILOC    --     -.30*     -.15           .42*     -.02 -.20* 
 
2. God LOC           --        .46* -.02    .30*  .12 
 
3. Chance LOC              -- -.20    .51*  .09 
 
4. Healthcare Providers LOC                 --    .05 -.07 
 
5. Powerful Others LOC                     -- .10 
 
6. HbA1c           --  
 
* p < .01 level 
 
centered external LOC variables were each multiplied by ILOC to create the following 4 
interaction variables; 1) ILOC X God, 2) ILOC X Chance, 3) ILOC X Healthcare Provider, and 
4) ILOC X Powerful Others.  Finally, the intercorrelations were performed for the centered 
variables in order to determine multicollinearity (see Table 16). 
Table 15 
Summary of Simultaneous Regression Analysis for Locus of Control Variables  
Predicting Adherence to Medical Regimens (i.e., HbA1C levels) (N=109) 
 
Variable     B  SE  Beta  Partial   
ILOC     -.35 .24  -.16  -.15  
 
God LOC    6.81 .19  .04  .04 
 
Chance LOC    -2.83 -.10  -.01  -.01 
 
Healthcare Providers LOC  8.85 .29  .03  .03 
 
Powerful Others LOC   .23 .22  .11  .10 
________________________________________________________________________ 
Note: R = .41; R2 = .17; SE = 2.21 (p > .01).  * p < .01 level 
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Next, in order to answer question 9, if adding the interaction variables accounted for 
more variance in predicting HbA1c levels above the main effects, a hierarchical multiple 
regression analysis was performed. The criterion variable was HbA1c and the first block entered 
consisted of the 5 types of locus of control. The second block consisted of the 4 interaction 
variables including ILOC X God, ILOC X chance, ILOC X healthcare providers, and ILOC X 
powerful others (see Table 17). Age was controlled for in this analysis and accounted for 13% of 
the variance found in the model and had a -.37 partial correlation coefficient with the criterion  
Table 16 
Intercorrelations Between Locus of Control Variables and Their Interaction Variables 
Scale    1    2     3  4            5   6   7 8 9 
Patients (N=109) 
1. ILOC  -- -.30 -.15 .42 -.02 .20 .25 -.35 .05 
 
2. God LOC   --   .46 -.02 .30 .01 -.09 .08 .04  
 
3. Chance LOC   -- -.20 .51 -.09 .01 .20 .02 
 
4. Healthcare Providers     -- .05 .10  .26 -.50 .09 
 
5. Powerful Others LOC      -- .04 .02 .07 -.15 
 
6. ILOC X God LOC     -- .58 .08 .29 
 
7. ILOC X Chance LOC      -- -.31 .37  
 
8. ILOC X Healthcare        -- .13 
 
9. ILOC X PO LOC          --    
 
variable. Results support the a priori hypothesis. The first step of the regression demonstrated an 
R2 of .17; however, after the second step was run in the regression, which included the 
interaction of ILOC with the four external scales, the R2 increased to .31 (see Table 17). By 
adding the interaction variables, an additional 14% of the variance in HbA1c levels was 
accounted for, which was not accounted for by the main effects alone (see Figure 5).  
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Further, the results suggest that the additional variance by the interactions could be 
attributed to the interaction of high ILOC and low chance LOC, which was also consistent with 
the a priori hypothesis. The interaction of ILOC and chance LOC is the only significant 
interaction variable in the regression. Further, partial correlations suggest the ILOC x Chance 
interaction is moderately related (-.26) to the criterion variable, HbA1c (see Figure 5). 
Question 10. Which predictor variables (i.e., internal, chance, powerful others, health care 
providers, God, internal x chance, internal x powerful others, internal x health care providers, and 
internal x God) accounts for the most variance in predicting HbA1c?  
 
A forward multiple regression analysis was performed to answer question 10.  HbA1c 
level was the criterion variable and the centered predictor variables were 1) ILOC, 2) God LOC, 
3) chance LOC, 4) healthcare provider LOC, 5) powerful others LOC, 6) ILOC x God LOC, 7) 
ILOC x chance LOC, 8) ILOC x healthcare provider LOC, and 9) ILOC x powerful others LOC. 
Once again, age was controlled for in this analysis and accounted for 13% of the variance found 
in the model and had a -.37 partial correlation coefficient with the criterion variable. The model 
was significant at a .01 level and accounted for 24% of the variance. Results showed that the 
only predictor variable that was included in the model was the interaction of ILOC x chance 
LOC, while all other predictor variables were excluded from the regression model (see Figure 6). 
This supports the a priori hypothesis that the interaction of ILOC and Chance LOC would be the 
strongest predictor of HbA1c (see Table 18). Further, scatterplot graphs (see Figure 7) and an 
evaluation of the data (Aiken & West, 1991) suggest that the interaction of a high rating of ILOC 
and a low endorsement of chance LOC is related to HbA1c.  That is, individuals with high 
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Table 17 
Summary of Hierarchical Multiple Regression Analysis for Locus of Control Variables  
for Predicting Adherence to Medical Regimens (i.e., HbA1C levels) (N=109) 
 
 Variable       B   SE  Beta           Partial  
 
 
Step 1  
 
ILOC     -.35 .24  -.16            -.15  
 
God LOC    6.81 .19  .04  .04 
 
Chance LOC    -2.83 -.10  -.01  -.01 
 
Healthcare Providers LOC  8.85 .29  .03  .03 
 
Powerful Others LOC   .23 .22  .11  .10 
 
Step 2  
 
ILOC      -.27 .24  -.11  -.11  
  
God LOC        1.28 .25  .01  .01 
 
Chance LOC    1.75 .28  .01  .01 
 
Healthcare Providers   6.35 .25  .03  .03 
 
Powerful Others LOC   .37 .24  16  .15 
 
ILOC X God LOC   -.24 .25  -.12  -.10 
 
ILOC X Chance LOC*  -.71 .27  -.35  -.26 
 
ILOC X Healthcare    -.28 .18  -.17  -.15 
 
ILOC X PO LOC     -.26 .20  -.13  -.13 
________________________________________________________________________ 
Note: R = .41, R2 = .17, SE = 2.20  (p < .01) for Step 1;  
Note: R = .55, R2 = .31, SE = 2.06 (p < .01) for Step 2;  
Note:  ∆ R2 = .14  from Step 1 to Step 2 (p < .01).  






























Summary of Forward Multiple Regression Analysis for Locus of Control Variables  
Predicting Adherence to Medical Regimens (i.e., HbA1C levels) (N=109) 
 
Variable Included in Model        B SE  Beta   Partial  
 
ILOC X Chance LOC*  -.68 .18  -.33  -.35  
________________________________________________________________________ 
Note: R = .48; R2 = .24; SE = 2.08 (p < .01) 
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Figure 6: Interaction of Internal and Chance Locus of Control in Predicting HbA1c 

















Figure 7: Scatterplot of Interaction of Internal and Chance Locus of Control in Predicting HbA1c 
High Internal LOC X 
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DISCUSSION 
The present study examined the relationship between multiple perceived control constructs 
and medical regimen adherence in medical patients with Type 2 diabetes. Specifically, the 
relationship between health LOC constructs (i.e., internal, God, chance, healthcare providers, & 
powerful others), and constructs taken from Bandura’s Social Learning Theory (i.e., self efficacy 
and outcome expectancy) were evaluated in relation to HbA1c, a biological indicator for 
adherence behaviors among diabetic patients. A variety of statistical analyses were employed to 
answer ten research questions related to this area of interest. The following is an interpretation of 
the findings related to those primary research questions, as well as a discussion relating the 
present findings with previous research. Finally, practical implications of this study will be 
reviewed.  
Internal Locus of Control, Self-Efficacy, and Outcome Expectancy 
Separating the Constructs 
Internal Locus of Control (ILOC), Self Efficacy (SE), and Outcome Expectancy (OE) were 
measured and treated as separate constructs in this study.  There have been very few studies 
examining the three constructs simultaneously, but some researchers have argued they are 
actually the same construct. The present results show empirical support that ILOC, SE, and OE 
are indeed separate constructs and related differently to health behaviors. As table 8 illustrates, 
ILOC was only weakly to moderately correlated with SE (r=.27) and OE (r=.25), suggesting that, 
even though the variables are related, each construct taps into a different aspect of perceived 
control. The present findings offer support for theorists in the past who have argued these 
constructs are different entities (Godding & Glasgow, 1985; Litt, 1988; Marshall, 1991; 
Wallston, 1992). Further, as hypothesized, all three variables were positively, but moderately 
(range of .25 to .31), correlated. This is congruent with previous research that has found average 
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correlations between perceived control constructs to range between .30 and .50 (Talbot et al., 
1997). Positive correlations between these constructs indicate that individuals who have higher 
ILOC related to their diabetes are more likely to have greater confidence in their ability to follow 
their doctor’s treatment recommendations for diet, exercise, medication, and glucose monitoring.  
Further, those individuals with greater ILOC were more likely to believe that actually performing 
said behaviors would result in better-controlled diabetes and better health outcomes.   
While SE measured the patients’ confidence to follow their medical regimens, ILOC 
assessed their actual beliefs regarding who is in control of their health outcomes. Finally, OE 
measured the patients’ general beliefs that following their medical regimens would result in 
improved health outcomes. As evidenced in table 7, patients in the present sample differed 
significantly in their ratings of these three perceived control constructs. In general, this sample 
had a relatively strong belief in ILOC. The mean score, out of a possible maximum of 6, was 
4.54 (SD=1.04), indicating that they believed they had some role in controlling their diabetes. 
Patients also had very high ratings of OE (M=92.40); however, patients reported relatively lower 
ratings of SE (M=67.29). These trends indicate that even though patients believed they were 
partially responsible for their diabetes (ILOC) and believed that following their medical regimen 
would lead to better controlled diabetes, they did not have high confidence that they could 
actually follow their healthcare providers’ recommendations to reap these benefits (SE). This is a 
particularly important finding because although patients had the relatively lowest ratings of SE, 
compared to the other two control constructs, SE was the most salient predictor for HbA1c 
levels.  In other words, even though patients may have had strong feelings of ILOC and OE, their 
feelings of confidence (SE) were ultimately the determining factor as to whether they did or did 
not adhere to their medical regimen, which is discussed below.  
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Medical Regimen Adherence 
ILOC, SE, and OE were expected to all be positively related to medical regimen 
adherence. Given that lower levels of HbA1c indicated better adherence, negative correlations 
between the three scales and HbA1c were expected.  As predicted, all three variables were 
negatively correlated with HbA1c; however, only ILOC and SE were statistically significant (see 
Table 8). Further, as indicated by the simultaneous regression (see Table 9), SE demonstrated the 
strongest relationship with HbA1c, ILOC was the second strongest related, while OE 
demonstrated the weakest relationship with medical regimen adherence.  
Self-Efficacy and HbA1c. Patients’ ratings of how confident they felt that they could 
follow their physician’s recommendations for taking care of their diabetes was the only variable 
related to HbA1c in the regression analysis (see Table 9) and was significantly related to HbA1c 
in the zero order correlations (see Table 8).  This is consistent with previous research that has 
repeatedly found SE to be one of the strongest psychosocial variables related to health behavior. 
Greater SE is related to adhering to exercise programs (Brawley & Rodgers, 1993; Kaplan, 
Atkins, & Reinsch, 1984; McAuley, 1991, 1994), quitting smoking (Bagozzi & Edwards, 1998; 
Haukkala, Uutela, Vartiainen, Mcalister, & Knekt, 2000), safer sex behavior (DiIorio, Dudley, 
Soet, Watkins, & Maibach, 2000; Fishbein et al., 2001; O’Leary, Goodhart, Jemmott, & 
Boccher-Lattimore, 1992), and performing recommended breast self-examinations (Alagna, 
Morokoff, Bevett, & Reddy, 1987; Rippetoe & Rogers, 1987). Further, previous researchers have 
also found that high rates of SE enhances adherence to diabetic control regimens (Glasgow et al., 
1989; McCaul, Glasgow, & Schafer, 1987). The present results corroborated earlier researchers’ 
findings regarding the important role SE plays in successful health behavior change.  
Internal Control and HbA1c. By simply examining the zero order correlations (see Table 
8) it appears that ILOC is significantly related to HbA1c. However, when evaluated in the 
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regression model, it becomes clear that patient perception of internal control of their diabetes 
was not a significant predictor variable of HbA1c when compared to other perceived control 
variables (see Table 9). In fact, the regression analysis showed that SE was the only significant 
predictor, out of the three perceived control variables, of HbA1c. Further, the fact that ILOC and 
SE were moderately correlated, coupled with the null findings for ILOC in the regression model, 
suggests that the zero order correlation found between ILOC and HbA1c was probably related to 
ILOC’s relationship with SE.  In other words, the significant relationship demonstrated in the 
zero order correlations was most likely due to the relationship between SE and HbA1c levels. 
From our findings it can be concluded that differences in HbA1c levels between the participants 
was not likely due to participants’ differences in beliefs about ILOC.  
Researchers have inconsistently supported ILOC’s role in health behaviors, and have 
more consistently demonstrated the link between SE and health behaviors (Stuare, Borland, & 
McMurray, 1994). The present results mirror this trend found in the diabetic and non-diabetic 
literature (Wallston, 1991; Wallston & Wallston, 1978; Wallston, Wallston, Smith, & Dobbins, 
1989).  Thus, when simply evaluating the main effect results of ILOC and HbA1c, the degree to 
which our patients reported beliefs that they controlled their diabetes had an impact upon their 
motivation to perform self-care behaviors (e.g., exercise, diet, taking medications). This was 
consistent with previous studies, which have demonstrated perceived internal control to be 
associated with better adjustment to diabetes (Burns, Green, & Chase, 1986; Hamburg & Inoff, 
1982; Helgeson & Franzen, 1998; Jacobson et al., 1990), better adherence to self-care regimens 
(Evans & Hughes, 1987; Jacobson et al., 1986), and better metabolic control (Brown, Kaslow, 
Sansbury, Meacham, & Culler, 1991; Konen, Summerson, & Dignan, 1993; Murphy, Thompson, 
& Morris, 1997; Reynaert et al., 1995; Stenstrom, Wikby, Andersson, & Ryden, 1998; Surgenor, 
Horn, Hudson, Lunt, & Tennent, 2000).  However, when further evaluated in conjunction with 
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other perceived control variables such as SE, ILOC does not show a significant relationship with 
adherence behavior, and it becomes apparent that the initial relationship that was demonstrated 
between ILOC and HbA1c was probably due to ILOC’s positive correlation with SE.  On the 
other hand, even though ILOC, in its solidarity, did not demonstrate a strong relationship with 
HbA1c, when combined with other perceived control constructs such as OE or types of external 
LOC, ILOC can be meaningfully related to diabetes related adherence behaviors.   
Outcome Expectancy and HbA1c.  OE was defined in the beginning of this paper as the 
belief that performing certain behaviors will result in expected outcomes.  For this study, 
participants were queried as to whether they believed following the specific aspects of their 
diabetic regimen (i.e., eating a diabetic diet, exercising, taking medication, testing their glucose 
regularly, following doctor’s orders) were important for glycemic control.  The present sample 
generally endorsed very strong beliefs that performing these behaviors is important in 
maintaining glycemic control and good diabetic health outcomes. This suggested that the patients 
were educated regarding what is important for the maintenance of diabetic control. On the other 
hand, even though patients felt following their regimen was important, OE was not found to be 
significantly related to actual adherence behaviors, as indicated by zero order correlations (see 
Table 8) and multiple regression analyses (see Table 9).  
Researchers have argued that the expectations of behavioral outcomes (OE) are important 
in predicting health behavior outcomes (Anderson et al., 2000; Hallam & Petosa, 1998; Morrill 
et al., 1996). The sense that a behavior will result in desired outcomes, more so than actual 
outcomes, can purportedly influence the likelihood that a behavior will be performed (Bandura, 
1997). Unfortunately, this contention was not supported by the present study’s findings.  It is 
unclear why OE was not related to medical regimen adherence in this diabetic population.  It 
may be that OE is important for some health behaviors such as condom use (Morrill et al., 1996) 
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or dietary fat reduction (Anderson et al., 2000), but is not related to overall adherence to a 
multifaceted diabetic regimen.  Further, it may be that the scale used in this study was worded in 
such a way that OE ratings overlapped with knowledge ratings (i.e., ‘how is important is taking 
your medication to control your diabetes?’).  If the OE scale was worded a little differently to tap 
into individual OE ratings (i.e., ‘do you think taking your medications will help control your 
diabetes?’), different results may have been found.  Previous researchers have repeatedly found 
knowledge to not be related to behavior choices or changes (Braithwaite & Thomas, 2001; Eiser 
& Cole, 2002; Wallace, Wright, Parsons, Wright, & Barlow, 2002); thus if the patients’ OE 
ratings were actually more an indicator of knowledge, the null results would not be surprising. 
And, in general, the OE scale used in this study less than optimal. However, given the lack of 
research in this area, there was a lack of diabetes specific alternatives to measure OE in medical 
patients. Further research is needed to develop more sensitive scales to measure the construct of 
OE and future research in this area may benefit from assessing knowledge with OE to determine 
the amount of overlap between the constructs. Finally, it should be noted that even though the 
null findings regarding OE were unexpected, it was posited that the interaction of OE with other 
perceived control variables would be meaningfully related to HbA1c levels in patients with Type 
2 diabetes.   
Interactions of Variables and HbA1c.  The interaction of the three perceived control variables 
(i.e., ILOC, SE, and OE) and their relationships with HbA1c was explored. Interaction variables, 
which represent the various interaction of the three constructs (ILOC x SE, ILOC x OE, and 
ILOC x SE x OE), were created and predicted to account for additional variance in HbA1c levels 
beyond the main effects of the independent constructs alone. As Table 11 illustrates, this 
hypothesis was supported by the hierarchical regression results. In step 1, SE was the only 
variable significantly related to HbA1c. The interaction variables were then added to step 2 and 
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contributed an additional 6% of variance, which was considered a statistically significant ∆ R2 in 
the model (p < .01).  Out of the three interaction variables entered, only ILOC x OE was 
significant in the regression model, suggesting that the interaction of high internal control and 
high OE is more important in determining HbA1c than the other two way interaction of ILOC 
and SE or the three way interaction of ILOC, SE, and OE.  
When the three perceived control constructs were evaluated in solidarity, ILOC and OE did 
not provide much information regarding adherence behaviors. In fact, if the analysis was 
terminated after the first step, without investigating the interaction of the perceived control 
variables, it may have been concluded that ILOC and OE were not meaningfully related to 
adherence behaviors. However, after the interaction variables were created and added to the 
regression, it was evident that even though SE continued to remain related to HbA1c, the 
interaction of ILOC x OE was also important in predicting medical regimen adherence. In other 
words, independently ILOC and OE were not good indicators for predicting HbA1c, but in 
conjunction the two variables were important in predicting adherence behaviors in diabetic 
patients. This is a novel finding that has yet to be published or discussed in the adherence 
literature, which warrants further research of the interaction of these constructs.  
A forward multiple regression analysis was performed to answer the question ‘which of the 6 
variables (ILOC, SE, OE, ILOC x SE, ILOC x OE, and ILOC x SE x OE) were the best 
predictors of medical regimen adherence?’  Not surprisingly, similar to the hierarchical 
regression, only two variables were significant in the model; SE and the interaction of ILOC x 
OE.  Further, the partial coefficients presented in Table 12, demonstrated that SE, independently, 
had the strongest relationship with HbA1c (-.36), while the interaction of ILOC x OE 
demonstrated the second strongest relationship (-.23).  In practical terms, this suggested that a 
diabetic patient’s feelings of confidence that he or she could adhere to his/her diabetic regimen 
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was important as to whether he or she actually followed the regimen. However, the interaction of 
ILOC and OE’s unique variance with HbA1c was also important because it suggested that when 
patients have high ILOC and high OE, they were also better at following their medical regimen, 
as evidenced by lower HbA1c levels.  
As previously stated, this interaction of ILOC and OE was paramount in predicting 
adherence compared to the other interactions of the perceived control variables. The interaction 
of ILOC, SE, and OE was expected to be the strongest predictor of HbA1c in this sample of 
diabetic patients.  This hypothesis was based predominantly on theory and not empirical 
evidence, since there is no literature that has previously looked at the relationship of these 
variables. Theoretically, a revised social learning theory (Wallston, 1992), combining Rotter’s 
Locus of Control Theory (1966) and Bandura’s Social Learning Theory (1986), was expected to 
demonstrate the strongest relationship with HbA1c, compared to the other interaction variables 
or the main effects of the perceived control variables alone (Wallston, 1992). Results did not 
support the theoretically based proposal of a revised social learning theory combining ILOC, SE, 
and OE.  Although we are unsure as to why the three way interaction was not significant related 
to HbA1c, it may be that the interaction of ILOC and OE accounted for the majority of the 
variance that was attributable to perceived control constructs.  Although it would seem 
reasonable to assume that the addition of SE combined with the interaction of ILOC and OE 
would only make the interaction variable a stronger predictor, this was not the case. From the 
present results it appears that SE, when evaluated alone, is meaningfully linked to adherence 
behaviors; however, SE does not interact with ILOC or OE in a meaningful way to influence 
adherence behaviors among Type 2 diabetics.  
In summary, out of the six-predictor variables, SE and the interaction of ILOC x OE 
demonstrated the strongest relationship with HbA1c. From this, it can be concluded that a person 
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with Type 2 diabetes is more likely to have a lower HbA1c level, which indicates better medical 
regimen adherence, if he or she has high SE alone or a combination of high ILOC and high OE. 
This person will have a greater chance at medical regimen adherence than a person with low SE, 
or a person with both low ILOC and low OE.  Although these variables appear to be important, it 
is notable that the variance accounted for in the regression analyses did not exceed 33%, which 
was with age accounting for approximately 10% of that variance as the controlled variable. Thus, 
only a moderate amount of the variance in HbA1c levels can be accounted for by these perceived 
control variables, which suggests that other variables must also be important in determining if 
medical patients were adherent with their diabetic regimens.  
External Health Locus of Control 
The Multidimensional Health Locus of Control Scales  
 This study was the first of its kind to examine the most recent version of the MHLC scale 
(Wallston et al., 1999) in a low-income, predominantly minority, medical sample with Type 2 
diabetes. The means and standard deviations for all 5 scales (i.e., internal, God, chance, 
healthcare providers, and powerful others) were presented in Table 7. The MHLC measured 
beliefs regarding patient control over his or her own health. The scale consisted of positively 
worded questions that asked patients how much they agreed with statements that covered five 
types of locus of control. Responses were based on a 6-point Likert scale with 1=strongly 
disagree, 2=disagree, 3=disagree a little, 4 = agree a little, 5 = agree, and 6=strongly agree. Raw 
scores were converted to averages that correspond to the original Likert scale to improve 
interpretability of the results. For example, this sample endorsed that their strongest belief was 
that their healthcare providers (M=5.05) are in control of whether their diabetes-related health 
worsens or improves. This trend has been found in past research with medical populations 
(Wallston et al., 1999). One reason may be that sampling from active medical attendees biases 
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ratings on the healthcare provider LOC scale. Further, it could simply have been that individuals 
who have stronger healthcare provider LOC are more apt to attend their medical appointments.  
Inversely, attending regular medical appointments for your diabetes may lead to stronger 
healthcare provider LOC. Given that the present sample consisted of all diabetic patients 
attending diabetic medical clinic appointments, it is likely the elevated ratings of healthcare 
provider LOC was influenced by one or all of these hypotheses.    
The second highest rated LOC scale was the internal scale (M=4.54) indicating that the 
patients also felt as though they were partly responsible for their diabetes.  Previous research has 
found somewhat elevated ILOC ratings for patients with diabetes (Macrodimitris & Endler, 
2001; Stenstrom et al., 1998; Surgenor et al., 2000). The endorsement of God LOC was the third 
greatest mean (M=3.07). However, given that a score of three corresponded with ‘disagree a 
little’ on the questionnaire, this rating suggested that on average the patients disagreed a little 
that God was in direct control of their diabetes.  The original study validating this additional 
subscale sampled patients with rheumatoid arthritis (Wallston et al., 1999) and demonstrated 
similar ratings for God beliefs (M =2.57). Further, another study (Chaplin et al., 2001) recently 
measured God LOC in a large sample of Canadian women and demonstrated mean ratings 
(M=3.28) similar to findings from the original validation study (Wallston et al., 1999) and to the 
present study.   
Finally, chance (M=2.50) and powerful others (M=2.46) LOC mean ratings were 
relatively equivalent. The patients did not endorse strong beliefs in these two types of LOC 
compared to the other three scales. Their ratings suggested that, in general, the patients disagreed 
with the statements that chance or others in their social network were responsible for their 
diabetes. This is similar to previous studies that have repeatedly found that people generally have 
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the weakest beliefs in chance and powerful others LOC (Chaplin et al., 2001; Wallston & 
Wallston, 1981).  
An interesting finding concerning the 5 types of LOC was related to racial differences 
found in LOC beliefs in our sample (see Table 5).  Blacks had significantly greater ratings of the 
God LOC scale than the Whites in this low-income population. This meant that the Blacks who 
participated in this study reported significantly stronger beliefs that God was in direct control of 
whether their health related to their diabetes than the White patients. Further, although it only 
approached significance with a p = .06 value, there was a trend that Blacks and Whites also 
differed in their ratings of healthcare provider LOC. Whites appeared to have stronger beliefs 
than Blacks that their healthcare providers were in control of their diabetes. There has been 
limited research examining racial differences in LOC, but our findings are similar to common 
trends found in other areas of research that 1) Blacks have stronger religious beliefs than Whites 
(Mansfield, Mitchell, & King, 2002); and 2) Blacks are more skeptical of modern medicine and 
healthcare providers than Whites (Corbie, Thomas, & St. George, 2002; Doescher, Saver, 
Franks, & Fiscella, 2000; Shavers, Lynch, & Burmeister, 2001). Although this was not a central 
question in this present project, these racial differences are intriguing and warrant more 
investigation.  
In summary, the present sample had the strongest beliefs that their healthcare providers 
controlled their diabetic outcomes. They also had relatively strong beliefs that they were in 
control of their diabetes. However, our sample somewhat disagreed that God, chance, or others 
in their social network, controlled their diabetes.   
Relationships Between the Five Types of Loci of Control  
 Based on previous literature testing the most recent version of the multidimensional 
health locus of control scale, hypotheses were made regarding how the scales would be 
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intercorrelated in a low income, predominantly minority sample.  Table 2 demonstrated the 
expected relationships between the five scales, while Table 14 shows the actual intercorrelations 
found in the present study.  It was predicted that ILOC would only be significantly correlated 
with health care providers LOC and that this correlation would be positive.  This hypothesis was 
supported (r = .42, p<.01) and is consistent with previous research that has demonstrated a 
positive link between ILOC and healthcare provider LOC beliefs (Wallston et al., 1994, 1999).  
That is, if a patient has a strong sense that she controls her health, she is also more likely to 
believe her physician also has some control over her health outcomes. Both ILOC and health 
care provider LOC have been linked with positive health behaviors (Peyrot & Rubin, 1994; 
Sensky & Petty, 1989; Stenstrom & Andersson, 2000).   
An interesting, though unexpected, finding was that ILOC was significantly related to 
God LOC. Previous research has not demonstrated a meaningful relationship between ILOC and 
God LOC (Wallston et al., 1994; 1999). However, the present finding, drawn from a low income, 
largely Black sample, suggested that ILOC and God LOC were negatively correlated (r= -.30, p< 
.01). In other words, our patients who endorsed ILOC beliefs were less likely to endorse God 
LOC beliefs. Similarly, the patients who reported belief that God was in control of their diabetes 
were less likely to also believe that they were in direct control of their health. This finding is 
notable given that previous research has not found this type of inverse relationship. Although not 
consistent with past studies, this was the first project to examine these constructs in a low-
income population, which may have to do with the discrepant findings. Finally,  ILOC was not 
significantly correlated with powerful others LOC, which supports previous findings that have 
failed to demonstrate a positive or negative relationship between the two scales (Wallston et al., 
1994; 1999). 
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 Although God LOC and ILOC were not expected to be related, it was hypothesized that 
God LOC would be positively correlated with chance LOC and powerful others LOC. These 
hypotheses were supported as demonstrated in Table 14.  God LOC was strongly correlated with 
chance LOC (r=.46, p<.01), which is consistent with previous work in this area (Wallston et al., 
1999). Patients who endorsed strong beliefs that God is in control of their diabetes, also tended to 
believe that their diabetes outcomes were a matter of fate or chance. Along the same lines, those 
individuals who did not report that they believe God was in control of their diabetes, tended to 
also reject the contention that their diabetes outcomes were a matter of fate or chance. A similar 
relationship was found between God LOC and powerful others LOC.  Beliefs in God were 
related to concurrent beliefs that other people’s behavior influences or controls one’s diabetes 
outcomes. Finally, as hypothesized, chance LOC and powerful others LOC were significantly, 
and positively, correlated.  Once again, this is consistent with previous investigations with the 
MHLC scale (Wallston et al., 1999).  
 In summary, the hypotheses regarding the relationships of the five loci of control scales 
were predominantly supported. The results were almost identical to previous research findings 
with the exception of the negative relationship that was found between ILOC and God LOC.  
External Loci of Control, Self-Efficacy, and Outcome Expectancy 
The relationships between the external loci of control scales and SE and OE were also 
examined in this study.  As discussed in the previous section, ILOC was meaningfully related to 
healthcare providers and God LOC. Intercorrelations were also performed on the four external 
subscales and SE and OE (see Table 13).  It was hypothesized that SE and OE would be 
negatively correlated with chance, God, and powerful others LOC, but positively correlated with 
healthcare providers LOC. Results supported these expected trends (see Table 13); however, the 
relationship between the variables were very weak. In fact, even though the variables were 
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correlated in the expected directions, none of the relationships between SE, OE and the four 
types of external LOC were statistically significant. This indicated that patients’ confidence in 
their ability to follow their medical regimen or their beliefs that following their medical regimens 
would result in favorable outcomes, were not related to their beliefs that external forces, such as 
God or chance, controlled their diabetes.    
Medical Regimen Adherence 
 External Health Loci of Control and HbA1c.  Each of the five types of LOC, internal as 
well as the four external scales, were examined regarding their relationship with HbA1c. Pearson 
R correlation coefficients of the five scales with HbA1c (see Table 14) suggested that only the 
internal scale was significantly correlated with medical regimen adherence, which was discussed 
in the previous section.  ILOC was more strongly related to medical regimen adherence in our 
sample of patients with Type 2 diabetes than the external types of LOC. In fact, ILOC not only 
had a stronger correlation with HbA1c, but it was the only type of LOC that was statistically 
significant in the correlation matrix; none of the four external scales demonstrated a meaningful 
relationship with HbA1c.  
Although the relationships between the external scales and HbA1c were not statistically 
significant, it should be noted that the directions of the correlations were similar to previous 
research findings (see Table 14). For example, previous studies have demonstrated that chance 
LOC and powerful others LOC are related to poorer adherence behaviors (Bradley, Lewis, 
Jennings, & Ward, 1990; Stenstrom et al., 1998). The present results demonstrated the same 
trend in a diabetic sample; chance (r = .09, p > .01) and powerful others LOC (r=.10, p > .01) 
were both positively correlated with HbA1c, indicating they were related to poorer adherence 
behaviors among these diabetic individuals.  
                                                                                               
 68 
On the other hand, previous research examining religious beliefs and health behaviors, 
have suggested that high God beliefs are positively related to recovering from illness (Pareek, 
2000) and better health habits in older adults (Welton, Adkins, Ingle, & Dixon, 1996). The 
present results were not statistically significant, but demonstrated a trend that God LOC was 
positively correlated with HbA1c, indicating that God LOC was related to poorer adherence 
behaviors (r=.12, p >.01).  However, also unlike previous research, the present study also 
measured internal control beliefs and found that they were negatively correlated with God 
beliefs. It may be a decreased internal LOC, which was negatively correlated with higher God 
LOC beliefs that significantly contributed to the trend that God LOC was related to poorer 
HbA1c levels.  Moreover, this was the first study of its kind that evaluated the impact of God 
LOC on medical regimen adherence in patients with diabetes who have very little resources, so 
the relationship between God beliefs and adherence behaviors may be different because the 
demographic makeup is different in our sample compared to past research.    
 Interactions of Internal and External Loci of Control and HbA1c. The stronger main 
effect found between ILOC and behavior is probably one of the reasons for the pervasive neglect 
of external scales in the LOC literature. However, the fact that external types of LOC do not 
independently influence adherence does not necessarily indicate that they are not related to 
behavior. A primary hypothesis of the present study was that the external scales would interact 
with ILOC and have stronger relationships with adherence behaviors than any of the LOC scales 
alone. To test this hypothesis, patients’ ratings of their ILOC were combined with ratings on 
each of the external scales to create four new interaction variables. These were ILOC x God, 
ILOC x Chance, ILOC x Healthcare Providers, and ILOC x Powerful Others LOC.  By creating 
these interactions, it was expected that more variance of HbA1c would be accounted for. 
Specifically, the interaction of ILOC and chance was expected to have a stronger relationship 
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with HbA1c than either of the variables independently.  As predicted, the results from a 
hierarchical regression, which entered into the interaction variables in Step 2 of the model, 
demonstrated a significant ∆ R2 of 14% by adding the interaction variables into the regression 
model (see Table 17 and Figure 6). On closer inspection, the interaction of ILOC and chance 
LOC was likely responsible for this additional variance, which is evidenced by its significance in 
the regression model and by its partial correlation coefficient.  
Finally, the findings from the simultaneous regression analysis presented in Table 18 
supported the final hypotheses made regarding the present study. Namely, out of the 9 predictor 
variables which were entered into the regression model, ILOC x Chance LOC was the strongest 
and only significant predictor of HbA1c (see Figure 6). High internal/low chance individuals had 
the best adherence to their diabetes regimen. This finding is consistent with results that have 
demonstrated that individuals who are more actively engaged in preventative health behaviors 
have stronger internal control beliefs and weaker beliefs in chance LOC (Wallston & Wallston, 
1981). Strong feelings of internal control, coupled with successful behavior change, may have 
bred weaker beliefs in chance LOC, making this type of high internal/low chance patient more 
likely to have lower HbA1c levels.   
Although the interactions of these variables have scarcely been studied, recently, a study 
by Stenstrom and colleagues (1998) demonstrated that individuals with Type I diabetes, who 
scored high on ILOC and low on chance LOC, had lower HbA1c levels than just high ILOC 
alone or any combination of external scales with ILOC. Although these researchers used a 
different scale to measure LOC and created their interaction variables by artificially 
dichotomizing LOC scores, they too used paper and pencil scales to measure LOC and used 
HbA1c, instead of self- report, to indicate general adherence. Once again, their results are 
surprisingly similar to the present researchers. Beyond the present study’s work with Type 2 
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diabetics and work by Stenstrom with type I diabetics (1998) LOC interactions have been 
neglected.  However, given the significant findings from the present study, further research is 
warranted.  
Limitations 
 There are some notable methodological limitations of the present study. First, as 
previously discussed, the present sample only consisted of patients attending medical clinics for 
diabetes treatment. Hence, this was not a good sampling of all diabetic patients, particularly 
those who are seriously non-adherent, as evidenced by the fact that they do not even attend their 
medical appointments. Along the same lines, the fact that our sample was drawn from a medical 
population may have affected the patients’ ratings of the psychological constructs. For example, 
the finding that the highest rating of LOC was healthcare provider LOC may have been 
influenced by demand characteristics. Although this may be a valid representation of their belief 
systems, the patients’ ratings of how important their healthcare providers are in controlling their 
diabetes may have been inflated from the fact that data was collected in a medical center while 
the patients were attending doctor appointments.  
A second methodological problem with this study was that the cross-sectional nature of 
this study did not allow the researcher to examine the stability of the patient’s perceived control 
constructs or their HbA1c levels. Through a longitudinal approach, richer information regarding 
how LOC may change over extended periods of time and how that may relate to disease 
progression, could have been gathered.  Another limitation of this study was that the majority of 
our patients were females and Black. This limits the external validity of the study and makes the 
generalizability of the study only applicable to other low income, Black, females and less so to 
groups with other demographic characteristics. Finally, although HbA1c level is a good overall 
indicator of medical regimen adherence in patents with Type 2 diabetes, it does not provide 
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specific information about adherence behaviors. However, the goal of this project was focused 
on overall adherence to medical regimens and not necessarily subcomponents of diabetic 
adherence behaviors. On the other hand, this is a good area for future research and one that 
HbA1c would not be as appropriate to use as an outcome measure. Alas, for the present study, 
HbA1c was a good indicator of general medical regimen adherence and circumvented common 
problems researchers face when using patient self-report measures of medical regimen 
adherence.   
Another general limitation of this study was that many of the patients more than likely 
had greater than one chronic illness. Although the patients were directed to respond based on 
their experience with Type 2 diabetes, responses may have been confounded by the presence of 
comorbid health conditions. Finally, it should be noted that the patients had a relatively restricted 
range in variance regarding their ratings of OE.  The reasons for this inflation and lack of 
variability are unknown; however, our scale that was supposed to measure OE, may have been 
tapping into knowledge regarding what behaviors are needed to control diabetes.  Patients who 
attend the diabetic clinic at EKL hospital are required to attend a multi-session education course 
on how to control diabetes. Had we sampled patients who were not attending the clinic, and who 
had not gone through these education courses, our ratings of OE may have been dramatically 
lower. A more sensitive scale may need to be used in the future to detect subtle differences in 
levels of OE.   
General Discussion and Conclusions 
 For decades, researchers, as well as healthcare providers, have attempted to determine 
why patients follow or fail to follow their medical treatment regimens.  This study does not 
answer this question in its entirety; however, it does shed light on the role of perceived control in 
patient adherence with Type 2 diabetic treatments.  Specifically, this study has expanded on 
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existing knowledge regarding the different types of perceived control and how these constructs 
do or do not determine general adherence behaviors. From the findings, it can be concluded that 
self-efficacy is the most salient type of perceived control that impacts diabetes-related health 
behaviors. Self-efficacy is a better predictor of adherence than internal locus of control or 
outcome expectancy.  This knowledge can be used to assist patients who are exhibiting poor 
adherence behaviors. Self-efficacy enhancing interventions can be created and implemented to 
improve patients’ metabolic control. This finding may also be used to identify newly diagnosed 
patients who may be at risk for poor adherence to their diabetic regimen. In this regard, feelings 
of confidence in following their doctor’s recommendations may be screened after diagnosis and 
intervention to identify patients with low self-efficacy.  Self-efficacy enhancing interventions 
may then be employed before poor metabolic control causes further health complications.  
Internal locus of control, independently, does not appear to be very important in 
predicting adherence behaviors.  Once again, given the pervasive inconsistencies regarding the 
role of internal locus of control in the diabetic and non-diabetic adherence literature, this is an 
important finding. Further, the original notion outlined in the introduction of this paper was that 
the concept of a larger construct, namely ‘perceived control’, would be more important in 
predicting behaviors than internal locus of control alone. In a sense, this contention was 
supported by the null findings regarding internal locus of control and the positive findings related 
to the interaction of internal control and outcome expectancy.  However, it was specifically 
stated that the construct of ‘perceived control’ would actually consist of a combination of 
internal locus of control, self-efficacy, and outcome expectancy.  This model was not supported 
by the present findings. The concept of ‘perceived control’ may very well be a conglomeration of 
various perceived control constructs; however, these findings suggest it is not the interaction of 
self-efficacy, internal locus of control, and outcome expectancy that forms this larger construct.  
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On the other hand, it was demonstrated that, when combined with other perceived control 
variables such as outcome expectancy and beliefs in chance locus of control, internal locus of 
control can play a more important role in influencing or predicting adherence to medical 
regimens.  This has important research implications. Namely, further research investigating the 
interaction of internal locus of control with other variables is needed. Research on health locus of 
control has been riddled with pessimistic reviews recently and it appears that Kenneth Wallston’s 
(1992) theory that internal locus of control is important but only when combined with other 
perceived control constructs, may be valid. This original argument made by Wallston (1992) was 
theoretical and not based on empirical findings, and, to date, he has not tested his own 
hypothesis. Although the present study did test and support Wallston's (1992) theory, further 
work is now needed to determine if the findings can be replicated.  
Further, this study tested the most recent MHLC scale in a low income, Type 2 diabetic 
population. The intercorrelations of the 5 loci of control scales were congruent with previous 
studies, which provides preliminary support for the use of this scale in low-income populations 
or simply with individuals with Type 2 diabetes. However, a novel finding regarding the new 
God locus of control scale was demonstrated. Interestingly, God locus of control, in this low 
income, predominantly minority, sample was significantly and negatively related to internal 
locus of control, which has not been demonstrated by previous research. Further, there was a 
trend in our results that the God scale was related to poorer adherence behaviors, which also has 
not been demonstrated in the past. Further replication research with the God scale, in similar 
populations, is also needed to determine if this finding is esoteric to individuals with similar 
demographic background.   
Finally, it should be noted that this study was, to our knowledge, the first of its kind to 
examine the impact of these types of constructs on adherence behaviors in a sample of low-
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income, individuals with Type 2 diabetes.  Because low-income individuals are less likely to 
engage in adaptive health behaviors (i.e., eating a good diet, following an exercise plan, taking 
medication) than middle/high- income individuals (Pamuk et al., 1998), it is beneficial that we 
have a basic understanding of what influences their health behaviors. From our findings, self-
efficacy appears to have an influence on the ability of low-income patients attending primary 
care clinics to follow their diabetic treatment plan.  A first step in decreasing the increased 
morbidity, mortality, and general health costs associated with non-adherence, that is widely 
found within disadvantaged communities, is the clarification of relationships between mediating 
variables, such as self-efficacy, and the ability to change health behaviors.  This study is an 
important step in investigating the causes of the disproportionate high rates of non-adherence in 
low-income individuals with Type 2 diabetes. 
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